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ABSTRACT 
 
 
 
Structural Insights into the Mechanisms of Membrane Binding and Oligomerization of a 
Bacterial Pore-forming Toxin. (December 2004) 
Rajesh Ramachandran, B.S., University of Madras; 
M.S., University of Madras 
Chair of Advisory Committee:  Dr. Arthur E. Johnson 
Perfringolysin O (PFO), a cytolytic toxin from by the pathogenic bacterium 
Clostridium perfringens, perforates mammalian cell membranes by forming large 
aqueous pores. Secreted as water-soluble monomers, the toxin molecules bind to 
cholesterol-containing membranes, form large, circular oligomeric complexes on the 
membrane surface and then insert into the bilayer to create pores with diameters near 
300 Å. Using multiple independent fluorescence techniques as primary tools, the 
mechanisms of PFO membrane binding and oligomerization have been identified. 
Domain 4 (D4) of the protein interacts first with the membrane and is responsible 
for cholesterol recognition.  Remarkably, only the short hydrophobic loops at the tip of 
the D4 β-sandwich are exposed to the bilayer interior, while the remainder of D4 
projects from the membrane surface. Thus, a very limited interaction of D4 with the 
bilayer core appears to be sufficient to accomplish cholesterol recognition and initial 
PFO binding to the membrane. 
Upon PFO membrane binding, a structural element in domain 3 (D3) of the 
molecule moves to expose the edge of a previously-hidden β-strand that forms the 
 iv
 
 
monomer-monomer interface. The β-strands that form the interface each contain a single 
aromatic residue, and these aromatics appear to stack to align the transmembrane β-
hairpins of adjacent monomers in the proper register for insertion. Membrane-dependent 
structural rearrangements are thus required to initiate and regulate PFO oligomerization. 
Fluorescence resonance energy transfer measurements reveal that the elongated 
toxin monomer arrives at the membrane in an ‘end-on’ orientation, with its long axis 
oriented nearly perpendicular to the plane of the membrane bilayer. This orientation is 
largely retained even after monomer association to form a prepore complex.  In 
particular, the D3 polypeptide segments that form the transmembrane β-hairpins remain 
far above the membrane surface both at the membrane-bound monomer and prepore 
stages of pore formation. However, upon pore formation, the height of the oligomeric 
complex above the membrane surface is significantly reduced. The major topographical 
changes that occur during the prepore-to-pore transition of the PFO oligomer, therefore 
appears to result primarily from a collapsing of the extended domain 2 (D2) 
conformation in the monomer. 
 
 
 v
 
 
 
 
 
 
 
 
For my Mother. 
 
 
 vi
 
 
ACKNOWLEDGMENTS 
 
 
 
First, I would like thank my mentor Dr. Arthur E. Johnson for his valuable 
suggestions, insightful comments, and incisive criticisms. Although a very hard act to 
follow, his discipline, commitment and dedication to the relentless pursuit of knowledge 
are truly inspirational. 
Very special thanks to Dr. Alejandro P. Heuck, my teacher, guide and friend, 
with whom I had the privilege to work and share ideas. His scathing but well-meaning 
criticisms on many an occasion has spurred me on to do my best. 
I would like to thank members of my advisory committee, Drs. James C. 
Sacchettini, J. Martin Scholtz, Michael Polymenis, and former member Dr. Hagan 
Bayley for their constant support and words of encouragement. 
Words fail me in expressing my heartfelt thanks to my dear friend, Gayathri 
Kalyanaraman, who stood by me and supported me through some trying times during the 
last few years. You are not only a great companion but also a wonderful human being. 
I would also like to thank my colleagues past and present for their friendship and 
support. 
Last, but not least, I would like to thank my parents back home in India, and also 
my brother for their love, support, and faith in me. I hope that I can live up to your 
dreams. 
 
 
 vii
 
 
TABLE OF CONTENTS 
 
 Page 
ABSTRACT ...........................................................................................................  iii 
DEDICATION .......................................................................................................  v 
ACKNOWLEDGMENTS......................................................................................  vi 
TABLE OF CONTENTS .......................................................................................  vii 
LIST OF FIGURES................................................................................................  x 
LIST OF TABLES .................................................................................................  xii 
CHAPTER 
I              INTRODUCTION ............................................................................  1 
Bacterial protein toxins .........................................................  2 
Pore-forming toxins (PFTs) .................................................  5 
S. aureus α-HL......................................................................  9 
CDCs .....................................................................................  10 
PFO structure.........................................................................  17 
Membrane-interacting regions of PFO..................................  19 
Mechanism of CDC pore formation......................................  25 
Pathway for CDC pore formation .........................................  27 
Unresolved issues and specific goals of this study ...............  29 
 
II             EXPERIMENTAL PROCEDURES ................................................  31 
Construction of recombinant PFO (rPFO) derivatives..........  31 
Overexpression and purification of rPFO derivatives...........  33 
Fluorescent labeling of rPFO derivatives..............................  36 
Preparation of liposomes.......................................................  39 
Assay for pore formation.......................................................  40 
Steady-state fluorescence spectroscopy ................................  41 
Collisional quenching by iodide ions ....................................  42 
Quenching by spin-labeled phospholipids ............................  43 
Time-resolved fluorescence spectroscopy and data analysis  45 
 
 viii
 
 
CHAPTER  Page 
FRET parameters, measurements and data analysis .............  46 
Calculation of acceptor density ...................................  46 
Determination of quantum yield QD.............................  47 
Determination of R0 .....................................................  47 
Steady-state anisotropy ................................................  50 
Energy transfer measurements .....................................  51 
Calculation of the distance of closest approach L........  52 
Chemical crosslinking and SDS-AGE ..................................  52 
III            MEMBRANE-ANCHORING MECHANISM OF PFO..................  54 
Introduction ...........................................................................  54 
Results ...................................................................................  56 
Experimental approach.................................................  56 
D4 does not span the bilayer ........................................  58 
Only the tip of D4 is exposed to the membrane core ...  60 
D4 orientation and contacts..........................................  61 
D4 topography in the membrane-inserted oligomer.....  65 
Discussion .............................................................................  65 
Role of D4 in pore formation .......................................  65 
 
IV           MECHANISM OF PFO OLIGOMERIZATION AND 
                     INTERSUBUNIT β-SHEET ALIGNMENT ...................................  70 
Introduction ...........................................................................  70 
Results ...................................................................................  73 
Experimental rationale .................................................  73 
β4 to β5 crosslinking inhibits oligomerization.............  75 
Membrane binding alters conformation near β4 ..........  79 
Loop flexibility is required for oligomerization...........  86 
β1 of one monomer is adjacent to β4 of its neighbor...  86 
Aromatic residues align intersubunit β-strands............  91 
Discussion .............................................................................  100 
Mechanism of PFO oligomerization and intersubunit  
β-sheet alignment .........................................................  100 
 
 V           TOPOGRAPHY OF MEMBRANE-BOUND PFO AT 
               DIFFERENT STAGES OF PORE FORMATION ...........................  106 
 
Introduction ...........................................................................  106 
Results ...................................................................................  110 
 ix
 
 
CHAPTER   Page 
Experimental rationale and design ...............................  110 
PFO derivatives trapped at  
different stages of pore formation ................................  113 
Spectral properties of BODIPY-labeled  
rPFO derivatives...........................................................  114 
Topography of PFO as a membrane-bound monomer .  115 
Topography of PFO in the prepore complex................  117 
Topography of PFO in the pore complex.....................  118 
Dye orientation (κ2) effects and uncertainties in L ......  120 
Discussion .............................................................................  122 
 
 VI          SUMMARY ......................................................................................  130 
 
REFERENCES ......................................................................................................  133 
APPENDIX SUPPORTING FIGURES.................................................................  142 
VITA .....................................................................................................................  148 
 
 
 
 
 
 
 
 
 
 
 
 
 x
 
 
LIST OF FIGURES 
 
 
FIGURE    Page 
1          Crystal structure of the S. aureus α-HL heptamer ..............................  11 
2          Comparison of the structures of LukF and α-HL.................................  12 
3          Primary structures of the sequenced CDCs..........................................  14 
4          Crystal structure of monomeric PFO ...................................................  18 
5          Origin of the transmembrane segments of PFO ...................................  22 
6          Top view of the pathway of pore formation by PFO ...........................  28 
7          Structures of fluorescent reagents and phospholipid............................  37 
8          Analysis of iodide ion quenching by the Stern-Volmer equation ........  44 
9          Spectral overlap of BODIPY and Rh-PE .............................................  49 
10        D4 probe locations ...............................................................................  57 
11        D4 probe environments ........................................................................  59 
12        D4 topography in the membrane-inserted oligomer ............................  66 
13        PFO structural elements and mutations................................................  72 
14        Conformational changes in D3.............................................................  74 
15        Effect of β4-β5 disulfide-locking on pore formation...........................  76 
16        Effect of β4-β5 disulfide-locking on membrane binding and 
            TMH insertion ......................................................................................  78 
17        Effect of β4-β5 disulfide-locking on oligomerization .........................  80 
18        D4-membrane interaction triggers a conformational change 
            around β4 in D3....................................................................................  84 
 xi
 
 
 
FIGURE    Page 
19 Effect of β4-β5 disulfide-locking on the conformational change 
around β4..............................................................................................  85 
20        Mutation of glycines at the end of β4 blocks oligomerization.............  87 
21        Pyrene excimer formation detects β1 and β4 proximity 
            in neighboring PFO ..............................................................................  90 
22        Excimer formation in the presence of the β4-β5 disulfide lock...........  92 
23        F318A mutation blocks pore formation but not membrane binding....  93 
 
24        F318A mutation blocks TMH insertion but not prepore formation .....  95 
25        Alignment of aromatic residues in β1 and β4 
            is critical for pore formation.................................................................  98 
26        Analysis of mutants i through iv ..........................................................  99 
27        Mechanism of oligomerization and intermolecular β-sheet formation  102 
28        PFO dimensions and locations of mutations ........................................  107 
29        Conceivable orientations of PFO on the membrane surface ................  109 
30        Dependence of energy transfer upon acceptor density.........................  116 
31        Model of FRET-detected changes in PFO topography ........................  128 
32        Pore formation by NBD-labeled D4 mutants .......................................  143 
33        Pore-formation assay for rPFO(V322C-NBD) 
            and rPFO(G324V G325V) ...................................................................  144 
34        Trp emission intensity time traces for rPFO mutants...........................  145 
35        Characterization of pyrene-labeled rPFO mutants ...............................  146 
36        Pyrene-excimer formation is dependent on the proximity of pyrenes .  147 
 xii
 
 
LIST OF TABLES 
 
 
TABLE      Page 
1          NBD exposure to the membrane interior ............................................   62 
2          NBD exposure to the aqueous milieu...................................................   63 
3          Fluorescence lifetimes of rPFO(V322C-NBD)....................................   82 
4          Fluorescence lifetimes of rPFO(F318A A215C-NBD)........................   96 
5          Distance of closest approach determined by FRET .............................   121 
 
 1
CHAPTER I 
INTRODUCTION 
Clostridium perfringens, the anaerobic bacterium that causes gas gangrene in 
humans, secretes an arsenal of tissue-damaging toxins into its host to elicit the various 
lesions and symptoms associated with the disease (Stevens and Bryant, 1999). The toxin 
primarily responsible is the ‘α-toxin’ that exhibits degradative enzymatic activities 
towards the mammalian plasma membrane leading to its disruption and permeabilization 
(Titball, 1999). The pore-forming perfringolysin O (PFO; also known as Θ-toxin) is 
another membrane-damaging toxin that plays a secondary, yet critical, role in 
establishing clostridial pathogenesis (Stevens and Bryant, 1999; Petit et al., 1999). In 
concert with the α-toxin, PFO contributes to the impairment of the host immune 
response by causing necrosis of the vasculature at the site of infection. PFO belongs to a 
large family of protein toxins called the ‘cholesterol-dependent cytolysins’ (CDCs) that 
form pores only in membranes that contain cholesterol (Alouf, 1999; Tweten et al., 
2001). 
The research in the following dissertation examines and elucidates mechanisms 
by which PFO anchors itself to a cholesterol-containing membrane and forms ring-like 
oligomeric complexes that ultimately insert into the membrane bilayer to create large 
aqueous pores. Beginning with an introduction, each successive chapter will address the 
molecular details of a specific step in the pore formation process, followed by an in 
                                                 
This dissertation follows the style and format of Cell. 
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depth discussion of the new findings and their impact on our current understanding of 
CDC pore formation.  
Bacterial protein toxins 
An evolutionary outcome of the host-pathogen relationship between higher 
eukaryotes and bacteria is the development of sophisticated virulence factors or toxins 
by the pathogen that give it a selective advantage over the host. These toxins are most 
often protein molecules that are designed specifically to either kill the host cell by lysing 
it or subvert host cellular processes such as cell signaling, intracellular protein sorting, 
and cytoskeletal assembly in order to create an ecological niche for the pathogenic 
bacteria to derive nutrients, effectively resist the host immune response, and thereby 
exert their virulence. Pathogenicity leads, in nearly all cases, to death. Thus, these 
molecules are, as the name implies, ‘toxic’ to the host.  This section will provide readers 
a brief introduction to the rapidly expanding field of toxin biology or ‘toxinology’ and 
its impact on human disease and health. For comprehensive reviews on bacterial protein 
toxins, I direct the reader to the following resource – The comprehensive source book of 
bacterial protein toxins (Alouf and Freer, 1999). 
 Since the isolation of the diphtheria toxin by Roux and Yersin in 1888, microbial 
toxins have been recognized as the molecular effectors of infectious disease (Schmitt et 
al., 1999). In the 1930s, diphtheria toxin was purified to sufficient quantities and was 
ascertained to be a protein. However, due to the limited knowledge on the nature of 
proteins then, fundamental concepts regarding protein toxins and their mode of action 
were not firmly grounded. Not until after World War II, when basic cellular processes 
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and their molecular bases were beginning to be unraveled, did scientific interest turn 
towards toxins and their role in altering host metabolism. The rapid advancement of 
biological sciences in the 60s and 70s saw seminal discoveries being made in toxin 
biology. In fact, debilitating diseases caused by Vibrio cholerae (cholera), Bacillus 
anthracis (anthrax), Bordetella pertussis (whooping cough), Clostridium perfringens 
(gas gangrene), Clostridium botulinum (botulism) and Clostridium tetani (tetanus) were 
all shown to be related to the protein toxins produced by these pathogenic bacteria.  With 
these discoveries came the application of inactivated toxins (toxoids) as vaccines to 
battle the invasive bacteria and their disease. 
 With a few exceptions (e.g. Listeria monocytogenes), growth of pathogenic 
bacteria within the host is extracellular. The protein toxins elicited by these bacteria are 
thus often secreted as soluble, diffusible moieties into the extracellular milieu of the host 
and in some cases are released by lysis of the bacterial cell (e.g. pneumolysin from 
Streptococcus pneumoniae). Hence, these toxins are referred to as ‘exotoxins’, as 
opposed to ‘endotoxins’ that are integral components of the outer membrane of Gram-
negative bacteria (e.g. lipopolysaccharides or LPS) and are usually liberated during 
bacterial lysis (Alouf, 1999).  
Although secreted into the extracellular milieu, a vast majority of bacterial 
exotoxins exert their deleterious effects by targeting molecules that are located within 
the host cytosol. For instance, toxins such as the Vibrio cholerae cholera toxin and the 
Bordetella pertussis pertussis toxin catalyze the ADP-ribosylation of the Gs subunit of 
heterotrimeric G proteins in the host cytosol that eventually leads to the disruption of 
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host signal transduction pathways (Hirst, 1999; Locht and Antoine, 1999).  Similarly, the 
Corynebacterium diphtheriae diphtheria toxin interferes with host protein synthesis by 
ADP-ribosylating the EF-2 elongation factor (Choe et al., 1992). 
How do toxins that act intracellularly move across the physical barrier posed by 
the host cell membrane? Most protein toxins that act on intracellular targets consist of 
two components: an ‘A’ or ‘active’ component that is responsible for the enzymatic 
activity of the toxin in the host cytosol, and a ‘B’ or ‘binding’ component that is 
involved in the binding of the toxin to a specific receptor on the host cell membrane and, 
by various mechanisms, in the translocation of the A moiety into the host cytosol. These 
toxins are referred to as ‘A-B’ toxins; the A and B components may or may not be 
encoded in a single polypeptide chain (Lacy and Stevens, 1998; Collier and Young, 
2003). For example, in the case of tripartite anthrax toxin, the lethal (LF) and the edema 
(EF) factors are the A components, while the protective antigen (PA) moiety constitutes 
the B component that forms a transmembrane pore through which the noncovalently-
associated A component is translocated into the host cytosol (for a review, see Collier 
and Young, 2003). This translocation takes place through the membrane of the acidified 
endocytic vesicle after internalization of the A-B complex by receptor-mediated 
endocytosis.  
On the other hand, in the diphtheria toxin, both the A and B moieties are present 
in a single polypeptide chain (Choe et al., 1992). The C-terminal portion of the B moiety 
associates with a specific transmembrane receptor on the host cell membrane (identified 
to be a heparin-binding protein; Naglich et al., 1992) and triggers the internalization of 
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the complex by receptor-mediated endocytosis. Acidification of the endocytic vesicle 
unfolds the toxin polypeptide and promotes the insertion of the highly hydrophobic N-
terminal portion of the B moiety into the endocytic vesicle membrane. This somehow 
facilitates the translocation of the N-terminal A moiety to the cytosolic side. Then, 
disulfide-bond reduction and proteolytic cleavage release the A chain into the cytosol, 
where it refolds and enzymatically ADP-ribosylates elongation factor-2 (EF-2) to inhibit 
protein synthesis. 
Thus, membrane-inserting, pore-forming toxin components constitute a portal for 
the entry of intracellularly-acting toxin moieties into the host cytosol. Since my study 
involves a pore-forming toxin, I will curtail my general description of bacterial toxins 
here and focus primarily on pore-forming toxins. 
Pore-forming toxins (PFTs) 
 Among the several different classes of protein toxins produced by pathogenic 
bacteria, a fair number of them (~ 35% of the 325 protein toxins identified so far) act by 
damaging host cell membranes (Alouf, 2001). Membrane damage constitutes any 
process that disrupts the integrity or the permeability barrier of the membrane bilayer. 
These toxins were first identified and characterized by virtue of their lytic activity 
towards mammalian red blood cells, earning them the name ‘hemolysins’. However, 
later studies showed that these toxins are active on a variety of cell types. Hence, they 
were rechristened as ‘cytolysins’ or ‘cytolytic toxins’ to accurately represent their mode 
of action (Alouf, 2001). 
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Membrane-damaging toxins can be organized into three main types: those that 
exhibit enzymatic activities towards the host cell membrane such as C. perfringens α-
toxin that exhibits metal ion-dependent phospholipase C and sphingomyelinase activities 
(Titball, 1999); those that solubilize the membrane via detergent- or surfactant-like 
activities, such as the S. aureus δ toxin (Dufourcq et al., 1999); and the PFTs that form 
sizeable holes in the host cell membrane and thereby surmount the permeability barrier 
conferred by it (Alouf, 2001). Action of these membrane-damaging toxins results in the 
rapid influx of water into the host cell, cell swelling, dissipation of electrochemical 
gradients, leakage of cellular contents, and ultimately, cell lysis.  
 PFTs are generally secreted by the bacteria as water-soluble monomers (e.g. PFO 
from C. perfringens) or in some cases, as dimers (e.g. Proaerolysin from Aeromonas 
hydrophila) (Buckley, 1999; Tweten et al., 2001). Upon encountering a target 
membrane, PFTs bind to high-affinity receptors and anchor themselves onto the target 
cell membrane surface. These receptors are highly varied and range from cholesterol 
molecules for cholesterol-dependent cytolysins (Alouf, 1999) to 
‘glycosylphosphatidylinositol-anchored proteins’ (GPI-anchored proteins) that bind 
toxins such as Clostridium septicum α-toxin (Gordon et al., 1999) and A. hydrophila 
aerolysin (Fivaz et al., 2001). On stable binding, the molecules diffuse laterally on the 
plane of the bilayer and undergo oligomerization, a hallmark property of PFTs.  
Oligomerization in discrete stoichiometries is accomplished either spontaneously or by 
the proteolytic removal of a polypeptide segment that presumably obscures the 
oligomerization interface. For example, inactive A. hydrophila ‘proaerolysin’ is 
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converted to active ‘aerolysin’ by the proteolytic removal of a peptide fragment by the 
host membrane-protease ‘furin’ (Fivaz et al., 2001). Oligomers formed by PFTs are 
essentially circular and are comprised of monomeric subunits ranging from seven (e.g. 
Staphylococcus aureus α-hemolysin (α-HL), A. hydrophila aerolysin) to more than forty 
(e.g. CDCs) (Heuck et al., 2001). Complete oligomerization into circular complexes then 
triggers the spontaneous insertion of these complexes into the membrane to create 
aqueous pores that range between 9 Å to 300 Å in diameter. 
 Structurally, PFTs can be classified into two types: α-PFTs that insert 
amphipathic α-helices into the membrane to line the aqueous pore and β-PFTs that form 
aqueous pores by insertion of an amphipathic β-barrel (Heuck et al., 2001). α-PFTs are 
best exemplified by the channel-forming ‘colicins’, a family of bacteriocidal PFTs from 
Escherichia coli. Colicin Ia is a particularly striking example of this family that forms 
small pores ~ 9 Å in diameter (Lakey and Slatin, 2001). A hallmark of this toxin 
molecule is the presence of buried hydrophobic helices in the water-soluble form of the 
toxin that are exposed upon target membrane binding and eventually insert into the 
bilayer. Other examples of α-PFTs include diphtheria toxin and the insecticidal δ-
endotoxin Cry from Bacillus thuringiensis (Lacy and Stevens, 1998). Since my study 
involves a β-PFT, I direct you to the following reviews for a discussion of α-PFTs 
(Gouaux, 1997; Lacy and Stevens, 1998; Lakey and Slatin, 2001). 
 β-PFTs, unlike α-PFTs, must oligomerize on the target membrane in order to 
generate the oligomeric transmembrane (TM) β-barrel. β-PFTs represent a growing 
family of proteins that are involved in bacterial pathogenesis and classic examples 
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include the S. aureus α-HL, A. hydrophila aerolysin, the Bacillus anthracis protective 
antigen (anthrax PA) and the CDCs of pathogenic Gram-positive bacteria (for a review, 
see Heuck et al., 2001). 
 TM β-barrels are ubiquitous from bacteria to man and are found in the outer 
mitochondrial and chloroplast membranes in eukaryotes and in the outer membrane of 
Gram-negative bacteria (Buchanan, 1999; Wimley, 2003). There, they serve as ‘porins’ 
for the passive translocation of a variety of small-molecular weight metabolites 
including sugars and siderophores. Recent experiments also implicate TM β-barrels in 
the translocation of unfolded polypeptide chains through the outer membranes of the 
mitochondrion and the chloroplast (Gabriel et al., 2001). Most TM β-barrels are 
comparatively small and contain as few as 8 (OmpA) or as many as 22 (FepA) β-strands 
(Schulz, 2000). In contrast, the β-barrels formed by β-PFTs vary widely in size, ranging 
from 14 β-strands in S. aureus α-HL and anthrax PA to about 200 β-strands in CDCs 
(Song et al., 1996; Heuck et al., 2001). Furthermore, while the β-barrels in the outer 
membrane of bacteria are usually formed by a single polypeptide [with the known 
exception of the trimeric β-barrel-forming TolC from E. coli (Koronakis et al., 2000)], 
those formed by β-PFTs are always oligomeric (Heuck et al., 2001). 
 TM β-barrel formation within the confines of the lipid bilayer involves the more-
or-less concerted insertion of all the β-strands that constitute the β-barrel (White and 
Wimley, 1999). Unlike the insertion of individual α-helices of a TM α-helical bundle, 
the pairwise insertion of single amphipathic β-hairpins is not energetically favored 
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because within the nonpolar core of the bilayer that lacks hydrogen-bond donors and 
acceptors, the transfer of non-hydrogen-bonded polar atoms of a β-hairpin-forming 
polypeptide is energetically costly. This cost is offset when the hydrogen bonding 
potential of the polypeptide is satisfied by matching backbone hydrogen-bond donors 
and acceptors and closing the β-sheet edges into a β-barrel. Thus, insertion of a 
preformed β-barrel or the formation of the β-barrel concomitant with membrane 
insertion is most favored as a mechanism for β-PFT pore formation (for an extensive 
review on TM β-barrel folding and insertion, see White and Wimley, 1999). Although 
no conclusive data exist for the timing of TM β-barrel formation and insertion in PFTs, 
it is presumed that a ‘prepore’ state (a complete circular oligomer poised for insertion) 
allows the concerted insertion of the β-hairpins from individual monomers. Furthermore, 
since the TM β-barrel is amphipathic, with nonpolar and polar sidechains facing the 
bilayer and the aqueous pore, respectively, concerted insertion of the β-hairpins to 
displace the lipids in the center of the pore seems most likely. 
S. aureus α-HL 
An important paradigm for pore formation by β-PFTs was established with the 
crystal structures of the detergent-solubilized S. aureus α-HL heptamer (Figure 1) and 
the water-soluble monomeric form of the homologous S. aureus LukF (Figure 2A) (Song 
et al., 1996; Olson et al., 1999). With each monomer contributing a single amphipathic 
TM β-hairpin, the mushroom-shaped α-HL heptamer formed a 14-stranded TM β-barrel 
that enclosed an aqueous pore ~ 15 Å in diameter. The structure of the water-soluble 
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monomeric form of LukF was found to closely resemble that of a monomer in the α-HL 
heptamer except at two different places. First, in the water-soluble form of LukF, the 
polypeptide stretch that eventually forms the TM β-hairpin was folded into three short β-
strands and packed against the core β-sheet in order to protect hydrophobic residues of 
the amphipathic β-hairpins from exposure of solvent. Second, residues 1-20 at the N-
terminus of LukF form a loop and a short β-strand that in the α-HL heptamer is 
significantly displaced and found to interact with the core β-sheet of the neighboring 
subunit. This N-terminal sequence is therefore termed the ‘amino-latch’. Although not 
experimentally demonstrated, it is presumed that membrane binding elicits these 
conformational changes in the α-HL monomer. Biochemical analyses also revealed two 
intermediate stages in the transition of the water-soluble monomer into a membrane-
inserted heptamer: the membrane-bound monomer (Walker et al., 1992) and the 
heptameric prepore complex poised for TM β-barrel insertion (Walker et al., 1995). For 
recent reviews on α-HL, see Prevost et al., 2001 and Montoya and Gouaux, 2003.  
CDCs 
The CDCs are a family of β-PFTs that serve as virulence factors for several 
genera of pathogenic Gram-positive bacteria (for a review, see Tweten et al., 2001). 
And, as their name implies, they are active or form pores only in membranes that contain  
cholesterol, a molecule that is unique to the membranes of higher eukaryotes. The CDCs 
are widely distributed and have been identified in 23 different species from five different 
genera of bacteria that include Clostridium, Streptococcus, Listeria, Bacillus and most 
recently, Arcanobacterium (Alouf, 2000). Although all CDCs are thought to operate via  
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Figure 1. Crystal structure of the S. aureus α-HL heptamer. The cap, rim and stem 
domains are labeled. One monomer in the heptamer is colored. The image was generated 
using MOLSCRIPT (Kraulis, 1991) and rendered with Raster3D (Merritt and Bacon, 
1997). 
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Figure 2.  Comparison of the structures of LukF and α-HL. Comparison of the crystal 
structures of the LukF monomer (A) and a monomer of the homologous α-HL heptamer 
(B) reveals regions of the monomer that undergo appreciable conformational changes 
during oligomerization and membrane insertion. The pre-latch conformation, the amino-
latch and the pre-stem/stem regions of the toxins are colored and labeled. The images 
were generated using MOLSCRIPT (Kraulis, 1991) and rendered with Raster3D (Merritt 
and Bacon, 1997). 
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a similar mechanism of action, they are known to fulfill diverse roles in establishing 
bacterial pathogenesis. For example, the CDC Listeriolysin O (LLO) form L. 
monocytogenes forms holes in the membranes of acidified phagocytic vesicles and, in 
concert with listerial phospholipases, dissolves the membrane and facilitates the escape 
of the phagocytosed bacteria into the host cytosol (Portnoy et al., 2002). In contrast, the 
CDC streptolysin O (SLO) from Streptococcus pyogenes is presumed to form holes in 
the host cell membrane that are used by the bacteria to inject enzymes and other effector 
molecules into the host cytosol, similar in mechanism to Type III secretion in Gram-
negative bacteria (Madden et al., 2001). 
At the molecular level, the CDCs are 50-70 kDa single-chain polypeptides that 
share 40-70% sequence identity (Figure 3) (Tweten et al., 2001). Based on the relatively 
high degree of sequence similarity, the CDCs are assumed to adopt similar three-
dimensional structures and modes of action. A striking feature in the primary sequence 
of 8 of the 11 sequenced CDCs is a highly conserved 11-residue sequence, 
ECTGLAWEWWR, situated near the C-terminus of the polypeptide. Modification of the 
Cys residue within this sequence (the only Cys in the entire molecule) with thiol-specific 
reagents was shown to completely inactivate the toxin (Iwamoto et al., 1987). In fact, the 
CDCs were previously referred to as ‘thiol-activated cytolysins or TACs’, since studies 
involving crude extracts containing these toxins were observed to lose activity over time 
and the addition of thiol-containing reducing agents such as dithiothreitol or β-
mercaptoethanol was found to restore activity, thereby suggesting that the loss of activity 
was due to the oxidation of protein Cys thiol(s) that was critical for the activity of these
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  Figure 3. Primary structures of the sequenced CDCs. Identical residues are boxed. 
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  Figure 3. (continued) 
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toxins (Billington et al., 2000). However, later experiments clearly demonstrated that the 
Cys did not play a substantial role since mutation of the Cys to Ala did not greatly alter 
the extent of pore formation (Pinkney et al., 1989; Saunders et al., 1989; Shepard et al., 
1998). These toxins have since been referred to as ‘cholesterol-dependent cytolysins’ 
because all members of the family exhibit an absolute dependence on the presence of 
cholesterol in the target membrane for their cytolytic activity (Tweten et al., 2001).  
As with other bacterial PFTs, structural dimorphism is a characteristic hallmark 
of the CDC family of toxins. The CDCs are secreted as water-soluble monomers into the 
extracellular milieu of the host. Upon encountering a cholesterol-containing membrane, 
the CDCs form large, circular homo-oligomeric complexes on the membrane surface and 
eventually insert into the bilayer to create large aqueous pores. Based on electron 
microscopy images, CDC pores have been estimated to be ~ 300 Å in diameter with each 
oligomeric complex containing ~ 50 monomers (Oloffson et al., 1993).  
The conversion of a CDC polypeptide from a stably-folded water-soluble form 
into an integrated membrane form is spontaneous.  This property is encoded in the 
structure of the CDC molecule itself, since the transformation is achieved without the 
assistance of other protein molecules (e.g. chaperones) or an energy source after being 
triggered by specific interactions with the target membrane bilayer (Heuck et al., 2001). 
How this is accomplished remains a fundamental issue that has intrigued researchers in 
the field for a long time.  
Inspection of the primary structures of the CDCs did not reveal any stretches of 
hydrophobicity that would be expected to insert into, and span, the nonpolar core of the 
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membrane bilayer (Figure 3). However, mutagenesis data indicated that residues in the 
conserved 11-residue sequence at the C-terminus are critical for pore formation, 
suggesting that they were directly involved in membrane insertion and presumably, in 
cholesterol binding (Iwamoto et al., 1987; Sekino-Suzuki et al., 1996; Jacobs et al., 
1999). The first speculation as to how CDCs penetrated the membrane bilayer came 
when the crystal structure of the water-soluble form of PFO was determined. 
PFO structure 
The three dimensional structure of the water-soluble monomeric form of PFO 
was solved at 2.2 Å resolution by X-ray crystallography and is the only high resolution 
structure of a CDC (Figure 4) (Rossjohn et al., 1997). The mature molecule (after signal 
sequence cleavage) composed of 472 residues, assumes an unusual elongated shape (115 
Å × 30 Å × 55 Å) and is rich in β-sheet. Based on the arrangement of the polypeptide 
chain within the structure, the molecule has been divided into three discontinuous 
domains (designated domains 1-3 or D1-3) and a contiguous C-terminal domain 
(designated domain 4 or D4). Domain 1 (residues 37-53, 90-178, 229-274, 350-373) is 
located at one end of the molecule and has both α-helix and β-sheet content, with a long 
helix packed against a 7-stranded antiparallel β-sheet. Domain 2 (residues 54-89, 374-
390), on the other hand, is simply a long, curved single-layer 3-stranded β-sheet that 
links domain 1 at one end of the molecule with domain 4 at the other. Domain 3 
(residues 179-228, 275-349) which extends from the core β-sheet of domain 1, adopts a 
α/β/α topology with a core 5-stranded β-sheet sandwiched between two layers of three 
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Figure 4. Crystal structure of monomeric PFO. Domains 1-4 (D1-D4) are colored and 
denoted. The image was generated using MOLSCRIPT (Kraulis, 1991) and rendered 
with Raster3D (Merritt and Bacon, 1997). 
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short α-helices each. Domain 4 (residues 391-500) adopts the ubiquitous β-sandwich 
fold comprised of two four-stranded antiparallel β-sheets. Interestingly, the highly-
conserved 11-residue sequence implicated in membrane insertion was found to form an 
extended, solvent-accessible loop at the tip of the domain 4 β-sandwich, where it 
appeared poised to interact with the membrane. This loop will hereafter be referred to as 
the ‘Trp-rich’ loop. 
Membrane-interacting regions of PFO 
Based largely on the location of D4 in monomeric PFO and also on the 
mutagenesis data, Rossjohn et al. (1997) proposed an attractive model for PFO 
membrane insertion in which the 29 Å long D4 β-sandwich completely inserted into the 
membrane bilayer to form the lipid-water interface of the aqueous pore in the oligomeric 
form of the toxin. The crystallographers also envisioned and modeled a binding site for a 
single cholesterol molecule in the crystal structure of the PFO monomer. They suggested 
that the Trp-rich loop in D4 undergoes a conformational change and creates a binding 
site for cholesterol that is sandwiched between the rearranged loop and one face of the 
D4 β-sandwich. The Trp-rich loop bound to a cholesterol molecule was then proposed to 
form a ‘hydrophobic dagger’ that completely spanned the membrane. Their model also 
included cholesterol molecules on the other face of the D4 β-sandwich to protect the β-
sheet’s hydrophilic face from the nonpolar core of the bilayer. In essence, domain 4 of 
each monomer was modeled with bound cholesterol molecules on both faces of the β-
sandwich while its edges were involved in intermolecular interactions with the β-
sandwich edges of neighboring monomers to create a D4 ‘β-barrel’ that interfaced the 
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aqueous pore and the nonpolar core of the lipid bilayer. All other domains of the PFO 
molecule were situated far above the plane of the membrane. 
This model was consistent with the following experimental observations. The 
PFO monomer was shown to undergo relatively modest changes in secondary structure 
upon membrane insertion by circular dichroism (CD) analysis (Nakamura et al., 1995). 
A proteolytically-derived C-terminal fragment (residues 304-500 that included D4) was 
able to interact with both the target membrane and intact PFO molecules on the 
membrane surface (Iwamoto et al., 1990; Tweten et al., 1991). Furthermore, some or all 
of the six Trp residues within D4 were shown to come into contact with the core of the 
membrane bilayer. This was determined based on the quenching of PFO Trp 
fluorescence by brominated lipids incorporated into cholesterol-containing liposomes 
(Nakamura et al., 1998). 
In apparent conflict with the details of model proposed by Rossjohn et al. (1997), 
cysteine-scanning mutagenesis and fluorescence spectroscopy data obtained with the 
CDC, SLO suggested that at least a part of D3 came into contact with the core of the 
membrane bilayer (Palmer et al., 1996; Palmer et al., 1998). This was determined by 
covalently attaching acrylodan, an environmentally-sensitive fluorophore to single 
cysteines engineered into the SLO polypeptide, and observing the changes in the dye’s 
emission spectra before and after pore formation. However, these data were fragmentary 
rather than complete and did reveal neither the structure of the polypeptide that 
contacted the bilayer nor its degree of membrane penetration. These observations formed 
the bases of further inquiry into the protein-membrane interactions of the CDCs.  
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Elegant fluorescence spectroscopy experiments with PFO later unequivocally 
demonstrated that the transmembrane regions of the molecule that form the interface 
between the aqueous pore and the nonpolar core of the lipid bilayer in the membrane-
inserted oligomer originate from D3 and not from D4 as previously suggested (Figure 5) 
(Shepard et al., 1998; Shatursky et al., 1999; reviewed in Heuck et al., 2001). In this 
ground-breaking series of experiments, residues 189-217 and 288-311 in D3 were 
substituted, one at a time, with a single Cys in a functional, Cys-free derivative of PFO 
(C459A). The water-sensitive fluorescent dye, NBD, was covalently attached to a single 
Cys at each position and the dye’s spectral properties were determined prior to, and 
after, pore formation in liposomal membranes. Movement of the NBD dye from a polar 
to a nonpolar environment results in a pronounced increase in its fluorescence lifetime 
(Heuck and Johnson, 2002). After PFO membrane insertion, the NBD dye detected an 
alternating pattern of aqueous and nonpolar environments every successive residue, 
thereby showing that these two stretches of polypeptide are in a β-sheet conformation. 
Had the membrane-interacting regions been α-helical, the dye would have detected a 
pattern of aqueous and nonpolar environments as predicted by a helical wheel analysis, 
as demonstrated recently in the case of equinatoxin II (EqtII) from the sea anemone, 
Actinia equina (Malovrh et al., 2003). 
Consistent with the idea that these segments in PFO formed two β-hairpins that 
interfaced the aqueous pore and the nonpolar core of the lipid bilayer, NBD probes 
exposed to a nonpolar environment were quenched by nitroxide moieties attached to the 
acyl chain of the phospholipids, while probes exposed to a polar environment were  
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Figure 5. Origin of the transmembrane segments of PFO. Initially, D4 (shown in blue) 
was proposed to span the membrane bilayer (Rossjohn et al., 1997). Location of the 
conserved 11-residue sequence (undecapeptide) implicated in membrane insertion is 
shown. Later, six short α-helices in D3 were shown to unfold to form the two TM β-
hairpins, TMH1 (red) and TMH2 (green), that each monomer contributes to the β-barrel 
(Shepard et al., 1998; Shatursky et al., 1999). The image was generated using 
MOLSCRIPT (Kraulis, 1991) and rendered with Raster3D (Merritt and Bacon, 1997). 
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quenched by hydrophilic iodide ions (Heuck and Johnson, 2002). These TM β-hairpins 
will hereafter be referred to as TMH1 (residues 189-217) and TMH2 (residues 288-311) 
(Figure 5). Interestingly, both TMHs were each folded into short α-helices in the water-
soluble PFO monomer. Thus, each PFO monomer was found to undergo a helix-to-sheet 
transition and contribute two amphipathic β-hairpins to the large TM β-barrel formed by 
the membrane-inserted oligomer. These structural changes were unprecedented among 
bacterial pore-forming toxins and constituted a new paradigm for the insertion of CDCs 
into target membranes. Thus, the CDCs were shown to be β-PFTs.  
Since D3 is the pore-forming domain, the model proposed by Rossjohn et al. 
 (1997) appears to be incorrect. This result then elicits the following questions: where is 
D4 in the oligomeric pore complex, and how does it interact with the membrane bilayer? 
As briefly mentioned earlier, six of seven highly-conserved Trp residues in PFO 
are located in the C-terminal D4, while a lone Trp is located in D1. Consistent with the 
widely-held view that the Trp-rich loop in D4 inserts into the membrane and is partly 
responsible for pore formation, Nakamura et al. (1998) found that the binding of PFO to 
cholesterol-containing vesicles is accompanied by an increase in Trp emission that can 
by quenched by bromine atoms attached to the acyl chain of phospholipids in the 
membrane bilayer. These data, coupled with the finding that the lone Trp in D1 does not 
contribute to the membrane-dependent change in Trp fluorescence intensity (Nakamura 
et al., 1998), suggested that a few or all of the surface-exposed Trps in D4 entered the 
bilayer during pore formation. 
To determine the extent of membrane penetration by D4, Heuck et al. (2000)   
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used nitroxide-labeled phospholipids with the quencher moiety located at different 
depths within the bilayer to measure the extent of quenching of D4 Trp emission 
intensity.  Surprisingly, the Trp emission intensity was quenched significantly only when 
the quencher moiety was located close to the surface of the bilayer, suggesting that D4 is 
not deeply inserted into the bilayer and is peripheral to the membrane. Yet these 
experiments provided only little information on the orientation of D4 on the membrane 
surface and did not reveal what regions of its β-sandwich structure, other than the 
perceived Trp-rich undecapeptide loop, came into contact with the membrane bilayer. 
Hence, in the absence of detailed structural information, the exact role of D4 in the pore 
formation process is unknown. 
Heuck et al. (2000) also compared the kinetics of the D4-specific change in Trp 
emission intensity upon membrane binding and the D3-specific change in NBD-
emission intensity when a probe attached to a membrane-facing TMH residue is inserted 
into the bilayer. These experiments demonstrated that D4-membrane interactions 
preceded the insertion of D3 TMHs into the membrane. They also showed that 
substitution of D3 TMH residues with Cys altered the rate of D4 binding to the 
membrane surface, even though D4 interacts first with the membrane. Furthermore, 
when insertion of the D3 TMHs was prevented by an engineered intramolecular 
disulfide bond between a TMH residue and D2, D4-membrane binding proceeded to 
completion. These data thereby revealed that the spatially-separated D3 and D4 are 
conformationally coupled. Thus, pore formation was shown to be accomplished by 
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sequential and ordered conformational changes that extended throughout the CDC 
molecule. 
Mechanism of CDC pore formation 
 A contentious issue that sparked widespread debate among researchers in the 
field involved the mechanism of assembly of the CDC oligomeric pore complexes in the 
membrane bilayer. Two conceptually different models were proposed for the mechanism 
of CDC pore formation. 
 Palmer et al. (1998), based on the extremely large size of the SLO pore, the 
perceived heterogeneity of the SLO oligomer, and the existence of arc-shaped pore 
structures in electron microscopy images of membrane-bound SLO, suggested that 
membrane insertion of a CDC molecule preceded its oligomerization. According to their 
model, CDC pore formation is triggered by the initial insertion of a dimer that serves a 
nucleus for oligomerization. Subsequent elongation of the inserted dimer by the insertion 
of individual monomers that rapidly associate yields a ‘growing’ arc-shaped pore that 
eventually becomes circular after the arc is completed. Consistent with their model, they 
provided evidence that the pore size could be manipulated by addition of a SLO mutant 
that ostensibly capped the ends of a growing oligomer and prevented further 
oligomerization. However, the ‘growing-pore’ model posed severe conceptual 
difficulties because it was not clear how the hydrophilic side of the two TMHs of an 
individual SLO monomer could be inserted into the nonpolar bilayer and retained in a 
stable form until pore formation was complete. 
In apparent contrast to the growing-pore model, results from four independent 
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studies suggested that the formation of a complete, circular, oligomeric ‘prepore’ 
complex is obligatory and occurs prior to the insertion of the CDC TM β-barrel.  
First, Shepard et al. (2000) demonstrated that the membrane-inserted CDC (PFO) 
oligomers (~ 2.5 MDa) were resistant to the detergent SDS. They showed that the large 
SDS-resistant PFO oligomer could be sieved on a SDS-agarose gel (SDS-AGE) and 
resolved from the monomer. Under low temperature conditions that significantly 
retarded the rate of insertion of the TMHs, they found that nearly 80% of the PFO 
monomers were present in SDS-resistant oligomers. The formation of circular prepore 
complexes prior to TM β-barrel insertion under these conditions was confirmed by a 
combination of SDS-AGE, electron microscopy, fluorescence spectroscopy, and ion-
conductivity measurements in planar bilayers.  
Second, Hotze et al. (2001) engineered a reversible, intramolecular disulfide 
bond in PFO that clamped TMH1 to D2 and showed that the disulfide-trapped molecules 
formed circular, prepore complexes on the membrane surface in the absence of any 
TMH insertion.  
Third, Hotze et al. (2002) discovered a point mutant of PFO in which substitution 
of a highly conserved Tyr in D3 (Y181) with a residue other than Phe (Y181A, Y181C) 
trapped PFO in the prepore state and completely abrogated pore formation. Furthermore, 
they also showed that the non-functional Y181A mutant could be forced to insert its TM 
β-hairpins into the membrane in mixed oligomers comprised of a molar excess of 
functional PFO, demonstrating that monomer-monomer interactions in the prepore 
complex are necessary to drive TM β-barrel insertion.  
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Fourth, Heuck et al. (2003) in a recent unprecedented comparative study showed 
that the CDCs PFO and SLO, when tested under the same conditions, formed only large 
pores. They demonstrated that the rate and extent of release of liposome-encapsulated 
markers of molecular dimensions ranging from small (0.6 kD) to large (670 kD) were 
superimposable under limiting toxin concentrations. These results are inconsistent with 
the notion of a smaller, rapidly-growing, arc-shaped pore that would be expected to 
release smaller markers at a faster rate than larger ones. Thus, the CDC pore is formed 
by the insertion of a large, discrete oligomer of a defined size and not by the growth of a 
smaller pore into a larger one by the addition of individual molecules. 
Pathway for CDC pore formation 
From the available data, the general pathway by which CDCs form pores in 
cholesterol-containing membranes can be delineated: 
Water-soluble monomer → Membrane-bound monomer → Membrane-bound 
prepore complex → Membrane-inserted pore complex (Figure 6).  
To briefly summarize each of these steps, membrane-targeting by CDCs is 
accomplished, presumably by the specific recognition of cholesterol in the membrane by 
D4. Whether cholesterol serves as a receptor for binding and/or is involved at a later 
stage in pore formation is still controversial. In synthetic liposomal membranes 
comprised of a binary mixture of phospholipids and cholesterol, a high amount of 
cholesterol (> 40 mol%) is absolutely required for binding (Heuck et al., 2000). In RBC 
membranes, near-depletion of cholesterol by methyl-β-cyclodextrin (MβCD) does not 
abrogate binding or prepore formation but does block TM β-barrel insertion instead 
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Figure 6. Top view of the pathway of pore formation by PFO. The gray surface 
represents intact membrane. The plane of the membrane is the same as the plane of the 
paper. 
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(Giddings et al., 2003). Further experimentation is required to clearly resolve this issue.  
Stable binding to the target membrane surface presumably triggers 
conformational changes in the CDC molecule that promote oligomer formation. 
Subsequent oligomerization of 40-50 monomers into circular, prepore complexes aligns 
the D3 TMH segments of adjacent monomers and triggers their concerted insertion into 
the membrane to form a large TM β-barrel. Concomitant with TM β-barrel insertion, by 
a mechanism that is still unclear, the lipid molecules in the middle of the pore are 
displaced to create a hole that measures ~ 300 Å in diameter. 
Unresolved issues and specific goals of this study 
As evident from the above narrative, our current understanding of the mechanism 
of CDC pore formation is fragmented rather than complete. For example, we do not yet 
understand the molecular details of the mechanism by which CDCs recognize a 
cholesterol-containing membrane. Other outstanding questions include the following: 
How do CDCs prevent premature oligomerization prior to target membrane binding? 
How does membrane binding trigger oligomerization? What conformational changes are 
elicited upon membrane binding? Where are the intersubunit interfaces in the CDC 
oligomeric complex? How are the TMHs of adjacent monomers aligned in proper 
register for β-barrel insertion? What are the topographical changes in the CDC molecule 
relative to the target membrane at different stages of pore formation? 
 In the case of smaller PFTs such as the S. aureus α-HL, high-resolution 
crystallographic structures have provided structural snapshots of the initial and final 
stages of pore formation, from which a pathway of pore formation has been delineated 
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(Montoya and Gouaux, 2003). Although high-resolution structures of the intermediate 
states in CDC pore formation are desirable, realistically speaking, with current 
limitations and difficulties in obtaining diffraction-quality crystals of membrane 
proteins, the idea of obtaining one with CDC oligomers that are heterogenous in subunit 
composition seems far-fetched. 
 Therefore, in the following studies, using PFO and synthetic lipid vesicles 
(liposomes) that permit pore formation as models for CDCs and the mammalian cell 
membrane, respectively, I have employed multiple independent fluorescence 
spectroscopic techniques as primary tools in answering the above-mentioned questions. 
 In toto, the combined data from the following studies have helped bridge many 
of the gaps that exist in our current knowledge of the mechanism of CDC pore 
formation. 
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CHAPTER II 
EXPERIMENTAL PROCEDURES 
Construction of recombinant PFO (rPFO) derivatives 
 The gene for PFOC459A (hereafter termed rPFO), the cysteine-free, functional 
derivative of PFO, was subcloned in the bacterial overexpression vector, pRSETB 
(Invitrogen) from its original vector, pRT20 (Shepard et al., 1998) via its Bgl II and 
EcoR I restriction sites (Heuck et al., 2000). The pRSETB vector containing the gene for 
rPFO was designated pAH21. In pAH21, the ORF of pfoC459A encoding amino acid 
residues 28-500 (residues 1-27 constitute the signal sequence for secretion from C. 
perfringens and are proteolytically removed) is placed under the control of the 
bacteriophage T7 promoter and fused in-frame to an N-terminal tag encoding 27 
residues that include a 6X-polyhistidine stretch for rapid purification of the protein 
product. The plasmid also provides an ampicillin-resistance cassette as a selectable 
marker. His-tagged rPFO was found to retain activity comparable to the wild-type 
(Heuck et al., 2000). 
This construct was used as the template for PCR-based site-directed mutagenesis 
using the Quikchange method (Stratagene). The basic codon replacement procedure 
utilizes two synthetic, complementary oligonucleotide primers (forward and reverse) 
containing the desired mutation(s) that anneal to their complementary sequence on 
opposite strands of the template plasmid except at the site of mutation. Complete 
extension of these annealed primers during thermal cycling by the high fidelity, 
thermostable DNA polymerase, pfuTurbo, generates a mutation-carrying plasmid with 
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staggered nicks. After treatment of the PCR mixture with Dpn I, a restriction enzyme 
that digests the methylated and hemi-methylated parental template DNA, the reaction 
mixture is used to transform sub-cloning grade competent bacteria. Cells carrying the 
repaired, mutated DNA are then selected based on ampicillin-resistance. After isolation 
of plasmid DNA (QIAGEN miniprep), the presence of the desired mutation(s) and the 
absence of random mutations in the mutated plasmid are confirmed by automated DNA 
sequencing.    
The mutagenic primers designed were between 25-45 nucleotides in length with 
melting temperatures (Tm) ranging between 60-80oC. The desired mutation(s) were 
typically in the middle of the primers. Primers were synthesized and purified by either 
Sigma-Genosys or Integrated DNA technologies, Inc. (IDT). The PCR reaction was 
performed in a volume of 50 µl containing 1 µl of template DNA (1 µl of a plasmid 
miniprep; ~ 30 ng/µl DNA), 1 µl each of forward and reverse mutagenic primers (125 ng 
of each primer), 1 µl of dNTP mix (50 µM final of each dNTP), 5 µl of 10X reaction 
buffer [200 mM Tris-HCl (pH 8.8), 100 mM KCl, 100 mM (NH4)2SO4, 20 mM MgSO4, 
1% (v/v) Triton X-100, 1 mg/ml nuclease-free bovine serum albumin (BSA)], 1 µl of 
pfuTurbo DNA polymerase (2.5 U/µl), and 40 µl of ddH2O. Thermal cycling parameters 
were 95oC (30 sec) for denaturation, 55oC (1 min) for annealing, and 68oC (2 min/kb of 
plasmid; 9 min) for extension. Typically, 16 cycles of PCR were performed for each 
mutagenesis. 
After PCR, the reaction was maintained at 37oC and 1 µl of the restriction 
enzyme, Dpn I (10 U/µl), was added directly to 50 µl of the PCR reaction mixture. This 
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mixture was incubated for 1 hour at 37oC to digest the methylated/hemi-methylated 
parental template DNA strands. Later, 1 µl of this reaction mixture was transferred to a 
microfuge tube containing 50 µl of freshly-thawed competent cells (Escherichia coli 
TOP10F’, XL-1 blue or MC1061 strains). This transformation reaction was gently 
mixed, incubated on ice for 30 min, and then heat-pulsed (heat shocked) for 45 sec at 
42oC. After the heat-pulse, the mixture was placed on ice for 5 min. Fresh SOC medium 
(250 µl) was then added to the bacterial suspension and the cells were grown at 37oC for 
1 hour with constant shaking (225-250 rpm). Later, 50-100 µl of the transformation 
mixture was spread on LB-Agar plates containing ampicillin (100 µg/ml) and incubated 
overnight at 37oC. Three or four colonies of transformed bacteria were picked, grown 
separately in 3 ml of LB (with 50 µg/ml ampicillin), and their plasmid DNA was isolated 
using the QIAGEN miniprep kit. The plasmid DNA was eluted in 50 µl of TE buffer 
[(10 mM Tris-HCl (pH 7.5), 1 mM EDTA)]. For automated DNA sequencing, 5 µl of 
the plasmid miniprep, diluted two-fold in ddH2O was submitted to Gene Technologies 
Lab (GTL) at Texas A&M University.   Forward or reverse mutagenic primers that were 
distant to the site of the desired mutation(s) were used as sequencing primers (50 
pmol/µl final) and the presence or absence of the desired mutation was confirmed. 
Overexpression and purification of rPFO derivatives 
 rPFO and its derivatives were overexpressed in E. coli BL21(DE3)pLysS or 
BL21(DE3) star (Invitrogen). Both these strains carry the gene for bacteriophage T7 
RNA polymerase under control of the IPTG (Isopropyl-β-D-thiogalactopyranoside)–
inducible lacUV5 promoter. Addition of IPTG induces the overexpression of T7 RNA 
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polymerase, which in turn drives overexpression of the rPFO constructs in pRSETB that 
are placed under the control of the strong T7 promoter. 
 Growth of BL21(DE3)pLysS or BL21(DE3) star cells carrying the plasmid for 
rPFO or its derivatives was initiated with a pilot culture grown overnight in 100 ml 
sterile LB (50 µg/ml ampicillin). The saturated overnight culture was then used as a 1:20 
inoculum for 2 liters of sterile LB (50 µg/ml ampicillin) in a 4-liter flask. The 2 liter-
culture was incubated at 37oC with constant shaking for about 3 hours until the OD600 
reached 0.5-0.6. Expression of rPFO constructs was then induced by the addition of 
IPTG to a final concentration of 1 mM. The induced culture was incubated further for 
another 4 hours before the cells were harvested by centrifugation in a Beckman JA-10 
rotor at 5000 RPM (RCF 4400 × g) and 4oC.  
 The following procedures were used for the purification of rPFO derivatives. 
Minor modifications to the protocol were made in the case of disulfide-bonded rPFO 
(see note at the end of this section).  
The cell pellet from the 2 liter-culture was suspended in 25 ml of buffer A [10 
mM MES (pH 6.5), 150 mM NaCl] containing protease-inhibitors benzamidine (0.5 
mg/ml final) and PMSF (0.1 mg/ml final). Cell lysis was achieved by two consecutive 
passages through a French pressure cell (Aminco) at 18,000-20,000 psi (cell pressure). 
Cell debris was removed by sedimentation at 15,000 RPM (RCF 31,000 × g) in a 
Beckman JA-17 rotor at 4oC and passage of the supernatant through a 0.45 µm-pore 
filter. The lysate was then loaded, via a bench-top peristaltic pump, onto a FPLC column 
(1.5 cm ID × 10 cm; Pharmacia) containing Chelating Sepharose Fast Flow resin 
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(iminodiacetic acid-Sepharose; Amersham) that was preloaded with Co2+ and 
equilibrated with buffer A at room temperature. Preloading of the Chelating Sepharose 
with Co2+ was achieved by passing a 5 mg/ml CoCl2 solution through the resin and 
washing away the excess unbound metal ions with buffer A. 
 At pH 6.5, the His-tagged rPFO derivatives bound to the Co2+-resin chelate, 
while most other contaminating proteins were discarded in the flow-through. To remove 
unbound contaminants, the resin was washed with 50 ml of buffer A. The column was 
then transferred to a FPLC (Pharmacia) unit and washed further with 65 ml (2 ml/min) 
of buffer A. This was followed by a 20 ml (2 ml/min) linear gradient of buffer B [1 M 
Imidazole (pH 6.5)] from 0 to 50 mM Imidazole to remove loosely-bound contaminants. 
After a 15 ml (2 ml/min) passage of 50 mM Imidazole, the concentration of Imidazole 
was raised to 300 mM in one step and His-tagged rPFO or its derivative was eluted in 
about 40 ml of 300 mM imidazole. The peak fractions were pooled (~ 40 ml) and 
dialyzed overnight at 4oC against 4 liters of buffer C [10 mM MES (pH 6.5), 1 mM 
EDTA, 0.5 mM DTT]. After removal of excess imidazole and metal ions by dialysis, the 
protein solution was loaded directly onto a 1.5 cm ID × 15 cm column containing the 
cation-exchange resin, sulfopropyl (SP) Sepharose (Amersham), equilibrated with buffer 
C. A linear gradient (3 ml/min) from 0 to 1 M NaCl eluted purified rPFO or its 
derivatives in a sharp peak at about 0.7 M NaCl. The fractions containing purified rPFO 
or its derivatives were pooled (~16 ml) and dialyzed overnight against buffer D [50 mM 
Hepes (pH 7.5), 100 mM NaCl]. After addition of 5 mM DTT (final), the protein 
solution was made 10% (v/v) in glycerol, aliquoted into 2 ml cryovials and flash-frozen 
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in liquid nitrogen. The quality of purification was assessed by polyacrylamide gel 
electrophoresis (PAGE: 12.5% gel) and the concentration of protein was determined by 
absorbance at 280 nm (A280) using a molar absorptivity coefficient of 74,260 M-1 cm-1.  
Note: In the case of disulfide-bonded rPFO (T319C V334C) and its derivatives, the 
bacteria were lyzed under slightly alkaline conditions [50 mM Tris-HCl (pH 8.0), 100 
mM NaCl] to promote formation of disulfide bonds. After initial purification by affinity 
chromatography using Co2+-chelating Sepharose under the same alkaline conditions, the 
pH was lowered to 6.5 by dialysis against buffer C lacking DTT. Disulfide-bonded rPFO 
was finally purified to apparent homogeneity by cation-exchange chromatography as 
described above. No DTT was added to any solution used to purify a disulfide-bonded 
rPFO derivative. No free sulfhydryls were detected in disulfide-bonded rPFO (T319C 
V334C) using dithionitrobenzene (Ellman’s reagent; Pierce Biotechnology protocol), 
thereby confirming that nearly all cysteines were engaged in disulfide bonds.  
Fluorescent labeling of rPFO derivatives 
NBD labeling of rPFO derivatives was done according to procedures described 
before (Shepard et al., 1998). Briefly, rPFO derivatives (between 5 to 10 µM) in buffer E 
were reacted with a 10-fold molar excess of IANBD (Molecular Probes; Figure 7), 
except that only in the case of rPFO(V322C), the reaction was made 3 M in guanidine 
hydrochloride to facilitate access of the IANBD to the partially-buried cysteine. NBD-
labeled rPFO derivatives were separated from the free dye by gel filtration through a 
Sephadex G-50 column (1.5 cm I.D. × 25 cm) equilibrated with buffer D. The efficiency 
of labeling was determined spectrophotometrically to be 80-100% [except for  
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Figure 7. Structures of fluorescent reagents and phospholipid. All fluorophores used in 
this study were obtained from Molecular Probes Inc. 
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rPFO(T319C V334C V322C], which was labeled to 30% in the absence of guanidine 
HCl), by using molar absorptivity coefficients of 74,260 M-1cm-1 at 280 nm and 25,000 
M-1 cm-1 at 478 nm for PFO and NBD, respectively. 
BODIPY labeling of rPFO derivatives was done similarly by using a 10-fold 
molar excess of BODIPY® FL C1-IA (Molecular Probes; Figure 7). The efficiency of 
labeling was determined spectrophotometrically to be 25-60% by using a molar 
absorptivity coefficient of 76,000 M-1 cm-1 at 502 nm for BODIPY. 
For pyrene labeling of rPFO(T179C), N-(1-pyrene)maleimide (Molecular 
Probes; Figure 7), was dissolved in DMSO and added in a four-fold molar excess to PFO 
in buffer E [50 mM Hepes (pH 8.0), 100 mM NaCl, 1 mM EDTA]; rPFO(V322C) was 
labeled in buffer B containing 3 M guanidine HCl. After incubation at room temperature 
for 2 hr, the reaction was quenched by the addition of DTT to a final concentration of 5 
mM (except in the case of disulfide-linked derivatives). After removal of precipitated 
material by sedimentation, the supernatant was passed through a Sephadex G-50 column 
(1.5 cm I.D. x 25 cm) equilibrated with buffer D to separate pyrene-labeled PFO from 
the dye-DTT adduct. The efficiency of labeling, determined spectrophotometrically 
using a molar absorptivity coefficient of 40,000 M-1cm-1 at 338 nm for pyrene, was 60-
70%, with the exception of rPFO(T319C V334C V322C) (50% labeled; no guanidine 
HCl in the reaction).  
All fluorophore-labeled rPFO derivatives were made 10% (v/v) in glycerol, 
flash-frozen in small aliquots and stored at -80oC before use. 
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Preparation of liposomes 
 Synthetic liposomal membranes comprised of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC; Avanti Polar Lipids, Inc) and cholesterol (Steraloids, Inc) at a 
ratio of 45:55 mol% respectively were generated using an Avestin Inc. Liposofast 
extruder and polycarbonate membranes (Whatman) of 100 nm pore diameter as 
described previously (Heuck et al., 2003). Briefly, the mixture in chloroform was dried 
and spread uniformly as a thin layer on the walls of a glass test tube by placing the 
solution under a stream of N2 gas at 37oC. To remove any traces of chloroform, the lipid 
mixture was further dried under vacuum at 37oC for an additional 3 hours. The 
thoroughly dried lipid mixture was then resuspended in pre-warmed (37oC) buffer D for 
30 min and vortexed thoroughly to remove lipids from the test tube wall and ensure their 
complete hydration. The volume of buffer D added to the dried lipid mixture was 
adjusted to yield a final lipid concentration of 5 mM (2.25 mM POPC; 2.75 mM 
cholesterol). The resuspended lipid mixture was subjected to 3 consecutive freeze/thaw 
cycles, and passed 21 times through a 100 nm polycarbonate membrane in a liposome 
extruder to generate large unilamellar liposomes. The liposomes were stored at 4oC and 
used within a week of production. 
Liposomes used in lipophilic quenching experiments were prepared using POPC 
and cholesterol in the same way, except that 10 mol% of the POPC was substituted with 
a nitroxide-labeled (spin-labeled) phospholipid, 1-palmitoyl-2-stearoyl-(12-doxyl)-sn-
glycero-3-phosphocholine (12-doxyl-PC; Avanti polar lipids, Inc), where the nitroxide 
moiety is covalently attached to the 12th carbon in the acyl chain of the phospholipid. 
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 Similarly, in liposomes used in FRET experiments, 1, 1.5 or 2 mol% of the total 
lipid was replaced with Rh-PE (Molecular Probes; Figure 7). 
Assay for pore formation 
Cholesterol-containing liposomes were prepared as above except that the dried 
lipid mixture was resuspended in buffer D containing 3 mM TbCl3 and 9 mM dipicolinic 
acid (DPA). Tb3+ (a lanthanide metal ion) and DPA together form a highly-fluorescent 
[Tb(DPA)3]3- complex. Free [Tb(DPA)3]3- was separated from liposome-encapsulated 
[Tb(DPA)3]3- by passing the mixture over a Sephadex G-50 column (1.5 cm ID x 25 cm) 
in buffer D at room temperature. The ability of unlabeled and fluorophore-labeled rPFO 
derivatives to form pores in cholesterol-containing liposomes was determined by 
measuring the release of the encapsulated [Tb(DPA)3]3- complex into an external solvent 
containing 5 mM EDTA. EDTA binds tightly to Tb3+ and quenches its fluorescence by 
displacing DPA from the [Tb(DPA)3]3- complex. Briefly, cholesterol-containing 
liposomes (50 µM total lipid) encapsulating the [Tb(DPA)3]3- complex were resuspended 
in buffer D containing  5 mM EDTA (pH 7.5) and placed in a temperature-controlled 
(25oC or 37oC as noted) cuvette (1 cm x 1 cm quartz) under constant stirring using a 
magnetic stir bar (1.5 mm Χ 8 mm). After thermal stabilization and complete mixing of 
the sample (5 min), the initial intensity (F0; zero time point) was determined. Then, the 
ability of rPFO derivatives (50 nM final) to form pores in these vesicles was determined 
by measuring the decrease in terbium emission intensity as a function of time, starting 15 
sec after toxin addition. The samples were excited at 278 nm (2 nm bandpass) and 
emission was monitored at 544 nm (2 or 4 nm bandpass) every 30 sec for the entire time 
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course of the experiment. Emission was monitored through an Oriel 5215 filter (0% 
transmittance below 350 nm) to remove second-order excitation light. 
Steady-state fluorescence spectroscopy 
Steady-state fluorescence measurements were made using an SLM 8100 photon-
counting spectrofluorometer with a 450 W xenon lamp light source, a double 
monochromator in the excitation light path, a single emission monochromator, and a 
Peltier-cooled PMT housing. Either 4 mm × 4 mm or 1 cm × 1 cm stoppered quartz 
cuvettes (Starna Cells, Inc) were used to house the samples for fluorescence 
measurements. 
For single-wavelength fluorescence measurements, the following excitation and 
emission wavelengths were used for the various fluorophores used in this study: Trp (λex 
= 295 nm, λem = 348 nm), pyrene excimer (λex = 345 nm, λem = 470 nm), NBD (λex = 470 
nm, λem = 530 nm), BODIPY (λex = 490 nm, λem = 510 nm); the band-pass was either 2 
or 4 nm for both excitation and emission. Typically, five 5-second integrations of 
emission intensity at a particular wavelength were taken in sequence and averaged to 
yield the recorded intensity measurement.  
For the acquisition of time-dependent emission intensity profiles for Trp and 
NBD, a sample containing rPFO or a derivative (final concentration 50 nM) in buffer D 
was stirred and temperature-equilibrated in a cuvette (1 cm x 1 cm quartz) before its 
initial intensity (F0; zero time point) was determined. Cholesterol-containing liposomes 
(50 µM total lipid) were then added to the sample, and data collection begun 15 sec later 
as above. Blank measurements were made using an otherwise identical sample that 
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lacked the fluorophore. The blank data were subtracted from the corresponding sample 
data, and F0 was corrected for dilution. 
 Fluorescence emission spectra for NBD and pyrene-labeled rPFO derivatives 
were recorded in either 4 mm x 4 mm or 1 cm × 1 cm quartz cuvettes under the same 
conditions described above. NBD was excited at 470 nm (4 nm bandpass) and emission 
intensity was measured between 500 nm and 600 nm (4 nm bandpass) at 1 nm intervals, 
while pyrene was excited at 345 nm (2 nm bandpass) and emission intensity was 
monitored between 360 nm and 550 nm (4 nm bandpass) at 1 nm intervals. 
To prevent photodegradation of the fluorescent probes, samples were stored in 
the dark prior to use.  In the fluorometer, shutters in the light path were kept closed until 
data collection began. 
Collisional quenching by iodide ions 
The extent of collisional quenching of NBD emission intensity by iodide ions 
was determined using the titration method as described before (Shepard et al., 1998). In 
this method, two equivalent samples containing NBD-labeled rPFO in buffer D at 25oC 
were titrated in parallel under constant stirring, one with 1 M KI and 1 mM Na2S2O3 and 
the other with 1 M KCl and 1 mM Na2S2O3 to yield final KI and KCl concentrations 
between 20 and 100 mM (5 points; 20, 40, 60, 80 and 100 mM) in the sample solution.  
Two equivalent control samples that lacked the NBD dye were also titrated in parallel 
with the same solutions and served as blanks in the experiment. The initial net 
fluorescence intensity for each sample (F0) was obtained prior to the addition of any KI 
or KCl by subtracting the background signal and light scattering of a corresponding 
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blank sample from its corresponding NBD-containing sample. After each addition of KI 
or KCl to a sample and its control, the emission intensities were measured and dilution-
corrected to obtain the net emission intensity (F). The net change in fluorescence due to 
quenching at each iodide ion concentration was then normalized using the equation: 
F0 / F = [(F0 / F)KI / (F0 / F)KCl] 
 The resultant data were then analyzed according to the Stern-Volmer law for 
collisional quenching of fluorescence, which is mathematically stated as: 
F0 / F = 1  +  Ksv [Q] = 1  +  kq τ0  [Q], 
where Ksv is the Stern-Volmer quenching constant and Q is the concentration of the 
quencher. Ksv is equal to kqτ0, where kq is the bimolecular quenching constant and τ0 is 
the fluorescence lifetime in the absence of quencher. kq was determined by a linear least-
squares analysis of (F0/F-1)/τ0 values at five different [I-] from at least three independent 
experiments. The slope of the plot yields kq. An example Stern-Volmer plot is shown in 
Figure 8. 
Quenching by spin-labeled phospholipids  
The emission intensities of two equivalent samples of monomeric NBD-labeled 
rPFO (50 nM) in buffer D were measured at 10oC (Fbuff), and then excess cholesterol-
containing liposomes (50 µM total lipid) with or without nitroxide-labeled phospholipids 
were added to the sample. After incubation of the mixture at 37oC for 30 min to allow 
pore formation, the samples were brought back to 10oC, and the NBD emission 
intensities were redetermined (Fmemb). The blank-subtracted, dilution-corrected 
intensities were normalized (Fmemb/Fbuff) to account for the differences in the NBD  
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Figure 8. Analysis of iodide ion quenching by the Stern-Volmer equation. Iodide ion 
quenching of water-soluble (?) or membrane-inserted rPFO(V403C-NBD) (?) was 
analyzed according to the Stern-Volmer equation: F0/F = 1 + kqτ0 [Q], where F0 is the 
emission intensity in the absence of quencher and F is the emission intensity in the 
presence of iodide ions at concentration [Q]. kq is the bimolecular quenching constant 
and τ0 is the fluorescence lifetime in the absence of quencher. A linear least-squares 
analysis of (F0/F-1)/τ0 values at five different [I-] yielded the value of kq (slope). 
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content of each sample. From these data, F/F0 was calculated, where F0 was the 
normalized NBD emission intensity in the nitroxide-lacking sample and F was the 
normalized NBD emission intensity in the nitroxide-containing sample. In the absence of 
quenching, F/F0 equals ~ 1, while in the presence of quenching, F/F0 <1. 
Time-resolved fluorescence spectroscopy and data analysis 
 Fluorescence lifetime measurements were made using an ISS (Urbana, IL) K2-
002 multi-frequency cross-correlation phase and modulation spectrofluorometer 
(Spencer and Weber, 1969). Samples were excited in 1 cm × 1 cm quartz cuvettes using 
the 457 nm or the 488 nm line of a Coherent (Santa Clara, CA) Innova 400-15/3 argon 
ion laser, and fluorescence emission was monitored through an Oriel OG-515 filter (0% 
transmittance of light with wavelengths less than 515 nm). To eliminate polarization 
artifacts (due to the effects of anisotropy on the intensity decay), magic-angle conditions 
were used in which the excitation light was passed through a vertically-oriented (0o) 
Glan-Taylor polarizer and emitted light collected through a Glan-Thompson polarizer 
oriented at 54.7o relative to the vertical axis (Spencer and Weber, 1970). No blank 
subtraction was done since scatter due to the presence of liposomes (both Raman and 
Rayleigh) was always less than 10% of the signal. For NBD lifetime measurements, 
disodium fluorescein (reference grade; Molecular Probes) in 0.1 M NaOH (τ = 4.05 ns) 
was used as the reference standard. 
Typically, samples containing 50-500 nM NBD-labeled rPFO derivatives in 
buffer D were incubated, either with or without an excess of cholesterol-containing 
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liposomes (PFO/lipid molar ratio, 1/1000), at 37oC for 45 min and then cooled to 25oC 
for 10 min before measuring the NBD lifetimes. 
 The phase and modulation data were analyzed using the computer program, 
GLOBALS UNLIMITED (University of Illinois, Urbana, IL) to compute the lifetime 
and mole fraction of dyes in each sample. Data were best fit (had the lowest χ2) to 
intensity decay models comprised of two components, either two discrete exponentials 
or one discrete exponential and one Lorentzian distribution. The latter adds an additional 
parameter corresponding to the half-width of the distribution. Fitting the data to three 
component models did not significantly improve the fit. Fractional contributions of each 
computed lifetime, expressed as pre-exponential factors, were interpreted to equal the 
relative mole fractions of NBD probes in the two environments (Crowley et al., 1993). 
FRET parameters, measurements and data analysis 
Calculation of acceptor density  
The surface density of Rh-PE molecules in acceptors per square angstrom, σ, 
was calculated by assuming that each cholesterol molecule occupies 37 Å2 of surface 
area, and each phospholipid molecule 48 Å2 of surface area in the presence of an 
equimolar ratio of cholesterol (Lecuyer and Dervichian, 1969). Thus, 
σ = [Rh-PE] / {([Phospholipid] × 48 Å2) + ([Cholesterol] × 37 Å2)}. 
Rh-PE concentrations of 1, 1.5 and 2 mol% yielded σ values of 2.4 × 10-4, 3.6 × 10-4, 
and 4.8 × 10-4 per Å2, respectively. 
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Determination of quantum yield QD 
The quantum yields of water-soluble and oxidized rPFO(T319C V334C E167C-
BODIPY)  and rPFO(T319C V334C A215C-BODIPY),  hereafter abbreviated as 
rPFODS(E167C-BODIPY) and rPFODS(A215C-BODIPY) to denote the intramolecular 
disulfide bond, were determined using the relationship: 
Q1 / Q2 = (F1 / F2) (A2 / A1)                  (Eq. 1) 
where Q1 is the quantum yield of  unreduced rPFODS(E167C-BODIPY) or 
rPFODS(A215C-BODIPY) in buffer D and Q2 is 0.92, the quantum yield of disodium 
fluorescein (Molecular Probes reference grade) in 0.1 M NaOH (Weber and Teale, 
1957). F1 and F2 are the integrated areas of the corrected emission spectra of the 
rPFODS(E167C-BODIPY) or rPFODS(A215C-BODIPY) and disodium fluorescein 
samples, respectively, recorded between 470-700 nm while A1 and A2 are the respective 
absorbances of the samples in their corresponding solvents at the exciting wavelength of 
460 nm. 
Determination of R0 
R0, the distance between a donor dye (D) and an acceptor (A) dye that yields a 
FRET efficiency of 50% was determined for BODIPY-labeled rPFO and Rh-PE in 
cholesterol-containing membranes using the equation: 
R06 = (8.79 × 10-5) κ2 n-4 QD  JDA                  (Eq. 2) 
where R06 is in Å6, JDA is the spectral overlap integral in M-1 cm-1 nm4, QD is the quantum 
yield of unreduced rPFODS(E167C-BODIPY) or rPFODS(A215C-BODIPY) in the 
absence of energy transfer, n is the refractive index of the medium between the D and A 
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dyes, and κ2 is a geometric factor that depends upon the relative orientation of the D and 
A dyes (discussed in Results). The absorbance spectrum of Rh-PE in cholesterol-
containing membranes and the corrected emission spectrum of the BODIPY dye in 
rPFODS(A215C-BODIPY) were recorded in buffer D at 1-nm intervals. JDA was then 
determined using 
JDA = ∫ FD(λ) εA(λ) λ4 dλ / ∫ FD(λ) dλ ,                                 (Eq. 3) 
where FD(λ) is the corrected net emission intensity of rPFODS(A215C-BODIPY) at a 
given wavelength and εA(λ) is the molar extinction coefficient of Rh-PE at the same 
wavelength. Using a molar extinction coefficient of 80,000 M-1 cm-1 at 567 nm for Rh-
PE, JDA was determined to be 2.05 × 1015 M-1 cm-1 nm4. The emission spectra of all 
BODIPY-labeled rPFO derivatives had the same shape (λmax = 511 nm) and yielded the 
same JDA values at all stages of pore formation. The spectral overlap of rPFODS(A215C-
BODIPY) and Rh-PE in cholesterol-containing membranes is shown in Figure 9. 
 Assuming values of 1.4 and 2/3 for n and κ2, respectively (Johnson et al., 1982; 
Mutucumarana et al., 1992; Yegneswaran et al., 1997), R0 for FRET between rPFO 
derivatives labeled with BODIPY at position 167 and Rh-PE in cholesterol-containing 
membranes was determined to be 52.2 Å, while that R0 for FRET between rPFO 
derivatives labeled with BODIPY at position 215 and Rh-PE was 53.4 Å. As discussed 
below and in Woolhead et al. (2004), it is reasonable to use κ2=2/3 to calculate R0. 
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Figure 9. Spectral overlap of BODIPY and Rh-PE. The corrected emission spectrum of 6 
nM rPFODS(A215C-BODIPY) (solid line) and the absorbance spectrum of Rh-PE (2 
mol%) (dotted line) incorporated into cholesterol-containing membranes (0.5 mM total 
lipid), both in buffer D were recorded at 1 nm-intervals. The molar extinction coefficient 
for Rh-PE is 80,000 M-1 cm-1 at 567 nm. The spectral overlap integral JDA was 
determined to be 2.05 × 1015 M-1 cm-1 nm4. 
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Steady-state anisotropy 
Steady-state anisotropies of BODIPY and rhodamine were measured in buffer D 
at 25oC using BODIPY-labeled rPFO derivatives bound to vesicles lacking Rh-PE and 
unmodified rPFO derivatives bound to Rh-PE-containing vesicles, respectively. The L-
format was used with Glan-Thompson prism polarizers in both the excitation and 
emission beams as described previously (Mutucumarana et al., 1992).  The emission 
intensity measured when a sample was excited by vertical plane-polarized light, and the 
emission detected through a horizontal polarizer was designated as IVH. IVV, IHV, and IHH 
were defined analogously. The component intensities of a dye-free blank sample 
containing the same concentrations of unmodified rPFO bound to vesicles that lacked 
Rh-PE were subtracted from the corresponding component intensities of the sample to 
obtain the net emission intensities of BODIPY-labeled rPFO derivatives and Rh-PE.  
The fluorescence anisotropy (r) was then calculated using the equation: 
r = (IVV – GIVH) / (IVV + 2GIVH),                                                                               (Eq. 4) 
where the grating factor G = IHV / IHH. λex and λem were 490 nm and 510 nm for 
BODIPY-labeled rPFO and 570 nm and 590 nm for Rh-PE. 
To eliminate homo-FRET between closely-spaced BODIPY-labeled rPFO in a 
membrane-bound oligomer that would reduce the fluorescence anisotropy, a mixture 
containing 6 nM of BODIPY-labeled rPFO and 94 nM of the corresponding unlabeled 
species (as in the FRET measurements) was incubated with cholesterol-containing 
membranes to spatially separate the labeled rPFO molecules in the oligomer. In 
experiments not shown, we determined that the anisotropy values do not change when 
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the ratio of unlabeled-to-labeled PFO is increased above 12:1. Similarly, to avoid homo-
FRET effects, we measured the anisotropy of Rh-PE using a σ of 0.6 × 10-4/Å2 (0.25 
mol%), a surface density considerably lower than that used in the FRET measurements. 
Energy transfer measurements  
 Four biochemically-equivalent samples were prepared in parallel for each energy 
transfer measurement: sample D (donor only) contained 6 nM of a BODIPY-labeled 
rPFO mutant and 94 nM of the corresponding unlabeled rPFO incubated with 
membranes lacking Rh-PE; sample DA (donor + acceptor) contained the same protein 
mixture incubated with cholesterol-containing membranes containing Rh-PE; sample A 
(acceptor only) contained 100 nM of the unlabeled rPFO mutant and Rh-PE-containing 
membranes; and sample B (blank) contained 100 nM of the same unlabeled rPFO 
derivative with membranes that lacked Rh-PE. In all four samples, the total lipid 
concentration of the cholesterol-containing membranes was 100 µM, and the 
concentration of Rh-PE was the same in DA and A. All samples were incubated at 37oC 
for 15 min to permit complete binding of rPFO derivatives to, and in some cases 
insertion into, the cholesterol-containing membranes. 
The net intensity of D, DA, or A (FD, FDA, and FA, respectively) was obtained by 
subtracting the blank signal (FB). The blank signal never exceeded 1% of the emission 
intensity of the D or DA samples. To correct for any signal in the DA sample caused by 
direct excitation of the acceptor, the net blank-corrected FA was subtracted from FDA. 
Making the reasonable assumption that the presence of the donor dye does not perturb 
 52
the absorptivity of the distant acceptor dyes, the ratio of the donor quantum yields in the 
absence and presence of the acceptor is then given by: 
QD / QDA = FD / (FDA - FA).                (Eq. 5) 
Calculation of the distance of closest approach L 
When the extent of energy transfer between randomly and uniformly distributed 
D dyes in one infinite plane and randomly and uniformly distributed A dyes in a parallel 
infinite plane is small, the first term in the approximate series solution of Dewey and 
Hammes can be used for calculating the distance of closest approach between the D and 
A dyes (i.e., the distance between the two infinite planes) (Dewey and Hammes, 1980). 
The measured QD/QDA values were therefore used to calculate L between BODIPY 
attached to rPFO mutants and Rh-PE dyes located at the membrane surface using: 
QD / QDA = 1 + (π σ R02 / 2) (R0 / L)4.                      (Eq. 6) 
QD/QDA values from multiple independent experiments were plotted as a function 
of the product of σ and R02. These combined data were analyzed using linear least-
squares regression analysis and from the slope of the plot, which is equivalent to 
πR04/2L4, L was determined. Use of eq. 6 is justified only when L > R0 (Baird and 
Holowka, 1985). In those instances, the extent of energy transfer to the acceptor dyes at 
the inner surface of the 50-Å-thick phospholipid bilayer is negligible and has not been 
included in our calculations. 
Chemical crosslinking and SDS-AGE 
Chemical crosslinking of rPFO derivatives with the homobifunctional amine-
crosslinker glutaraldehyde (Sigma) and denaturing agarose gel electrophoresis in the 
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presence of SDS (SDS-AGE) were performed as described previously (Shepard et al., 
2000), except that agarose (GeneMate) was used at a final concentration of 2% (w/v). 
Briefly, samples containing 0.4 to 2 µM NBD-labeled rPFO were incubated with an 
excess of liposomes (PFO/lipid molar ratio 1/1000) at 37oC for 30 min in buffer D. After 
the incubation, one-half of each sample received 5 mM glutaraldehyde for 2 min at room 
temperature before the reaction was quenched by the addition of 1 M urea (final), 
whereas the other half received no glutaraldehyde. The samples were then solubilized 
with SDS-sample buffer [50 mM Tris.HCl (pH 6.8), 0.6% (w/v) SDS, and 15% (v/v) 
glycerol (all concentrations final), with a trace of bromophenol blue] and resolved in a 
2% (w/v) SDS-agarose gel in SDS-gel reservoir buffer [50 mM Trizma Base, 400 mM 
glycine, 0.125% (w/v) SDS]. The gel was run at 100 V for 30 min and the resolved 
protein bands were visualized either by Coomassie blue staining or by NBD emission 
(for NBD-labeled rPFO) by exciting and scanning the gel with the 488 nm laser line of 
the Bio-Rad Molecular Imager FX. 
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CHAPTER III 
MEMBRANE-ANCHORING MECHANISM OF PFO* 
Introduction 
A fundamental issue associated with the mechanism of action of any pore-
forming protein is the identity and structure of the polypeptide that inserts into the 
membrane and forms the interface between the aqueous pore and the nonpolar lipid 
bilayer. Early studies with PFO showed that a proteolytically-derived C-terminal 
fragment (residues 304-500) is able to interact with both the target membrane and intact 
PFO molecules on the membrane surface (Iwamoto et al., 1990; Tweten et al., 1991). In 
addition, some of the six Trp residues within this fragment come into contact with the 
core of the membrane bilayer (Nakamura et al., 1995; Nakamura et al., 1998). Also, 
amino acid substitutions in a highly-conserved 11-residue sequence (residues 458-468) 
dramatically inhibit PFO pore formation (Sekino-Suzuki et al., 1996). The three-
dimensional structure of the water-soluble PFO monomer was subsequently determined, 
and the C-terminal portion of PFO (residues 391-500, designated D4) was found to fold 
into a separate β-sandwich domain comprised of two four-stranded β-sheets at one end 
of the elongated protein (Rossjohn et al., 1997) (Figure 5).  
Based largely on the location of D4 in monomeric PFO and on the above 
biochemical and genetic data, Rossjohn et al. (1997) proposed that D4 undergoes a 
conformational change and inserts completely into the bilayer to form the lipid-water 
                                                 
*Reprinted with permission from Ramachandran, R., Heuck, A.P., Tweten, R.K., and Johnson, A.E. 
(2002). Structural insights into the membrane-anchoring mechanism of a cholesterol-dependent cytolysin. 
Nat. Struct. Biol. 9, 823-827. 
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interface of the aqueous pore in the membrane-inserted oligomer.  
However, recent studies have unequivocally demonstrated that six short α-
helices in D3 unfold to form two TM β-hairpins, designated TMH1 and TMH2 (Figure 
5). These TMHs then join with those of other PFO molecules in the oligomer to create 
the TM β-barrel that defines the pore. Although D4 does not contribute to this β-barrel, 
other studies have shown that D4 interacts directly with the membrane (Iwamoto et al., 
1990; Tweten et al., 1991; Nakamura et al., 1995; Heuck et al., 2000). Thus, there has 
been great interest in the nature of the interactions of D4 with the membrane and with 
neighboring monomers in the oligomeric complex. 
We have recently shown that pore formation requires the sequential and coupled 
interaction of D4 and the spatially-separated D3 (residues 179-228 and 275-349) of PFO 
with the target membrane. Kinetics experiments using domain-specific fluorescent 
probes showed that D4 at one end of the elongated PFO monomer (Figure 5) interacts 
first with the membrane, yet mutations in D3 can alter the rate of the D4-membrane 
interaction (Heuck et al., 2000). This discovery raises important structural issues. Since 
D4 binds first to the membrane, how does the molecule reorient to allow the TMHs to 
insert into the bilayer during pore formation (Figure 5)? Does D4 also insert into the 
membrane? Is PFO oriented parallel to the membrane in the complex, with D4 lying 
along the membrane surface, to position the TMHs in D3 at the membrane surface? Is 
D4 involved in monomer-monomer interactions during the highly cooperative pore 
formation process (Hotze et al., 2002)?  
As a first step toward addressing the above questions, we have determined the 
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topography of D4, the domain responsible for PFO recognition of cholesterol at a 
membrane surface, using multiple independent fluorescence techniques. Our data reveal 
that: D4 does not span the membrane; only the tip of the D4 β-sandwich is exposed to 
the nonpolar core of the bilayer; D4 projects out of the surface instead of lying along it; 
and contact areas between D4 and adjacent monomers, if any, are small. 
Results 
Experimental approach 
Site-specific fluorescence labeling and various fluorescence spectroscopic 
techniques have been used successfully to identify regions of the PFO polypeptide that 
span the membrane bilayer (Shepard et al., 1998; Shatursky et al., 1999). In this 
approach, a single amino acid residue in a cysteine-free protein is replaced with a 
cysteine and its sulfhydryl moiety is covalently modified with the water-sensitive 
fluorophore, NBD (Figure 7). After ensuring that the function of the protein is not 
compromised by mutagenesis and/or modification, the spectral properties of the 
fluorescent dye are monitored before and after association of the labeled protein with the 
target membrane. Movement of the NBD dye from an aqueous milieu to a hydrophobic 
environment, such as the core of a membrane bilayer, is characterized by a dramatic 
increase in NBD fluorescence lifetime (τ) from about 1 ns in water to more than 7 ns in 
the interior of the membrane (Crowley et al., 1993). This spectroscopic technique 
therefore allows one to ascertain the environment of the residue to which the dye is 
attached, both before and after pore formation (Heuck and Johnson, 2002). 
Here, a single cysteine was introduced, one at a time, at 12 different locations on 
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Figure 10.  D4 probe locations. D4 is shown in a ribbon representation (A) and two 
space-filled representations rotated 180o relative to each other (B). Residues substituted 
with Cys to attach the NBD fluorophore are highlighted in (B): 397, 423, 433, 442, 455, 
474, 480, and 495 in red; 403 and 491 in purple; and 401 and 437 in yellow. Probe 
position corresponds to the residue number in the polypeptide chain. The images were 
generated using InsightII (Accelrys). 
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the surface of D4 (Figure 10) in a derivative of PFO that lacks the single natural 
cysteine, PFO (C459A), hereafter termed rPFO. The single cysteine in each rPFO 
mutant was then covalently modified with NBD. The pore-forming activities of NBD-
labeled forms of each of the rPFO mutants, assayed by monitoring the leakage of 
liposome-encapsulated [Tb(DPA)3]3- (see Experimental Procedures), were comparable to 
that of the parent toxin, rPFO, with the exception of rPFO(L491C) that formed pores 
slowly with or without the NBD modification (Appendix, Figure 32). 
D4 does not span the bilayer  
Time-resolved fluorescence measurements revealed the environments of NBD 
dyes at various locations on the surface of D4 both before and after pore formation 
(Figure 11). We observed that the fluorescence lifetime of probes located at positions 
401, 403, 437 and 491 of PFO, each located in a loop at the tip of the molecule (Figure 
10, yellow and violet), were short (0.5-0.8 ns) in the water-soluble monomer, but were 
long (> 7 ns) in the membrane-inserted oligomer. Thus, these probes moved from an 
aqueous milieu into a hydrophobic environment during pore formation in cholesterol-
containing liposomes. In contrast, the short fluorescence lifetimes of probes placed at 
eight other positions on the D4 surface (397, 423, 433, 442, 455, 474, 480 and 495) did 
not change significantly (Figure 10, red). Hence, these probes were still in an aqueous 
milieu following pore assembly. However, since a nonpolar environment could be 
provided either by the hydrophobic core of the membrane bilayer or within a 
hydrophobic monomer-monomer interface of the oligomeric complex, further 
experiments were necessary to ascertain the exact location of the probes.  
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Figure 11. D4 Probe environments.  Fluorescence lifetimes of NBD probes in water-
soluble monomeric PFO (?) and membrane-inserted oligomeric PFO (?) were measured 
and analyzed as described in Experimental Procedures. In the case of the water-soluble 
monomer, the data were best fit (i.e., had the lowest χ2) to two discrete lifetimes. For the 
membrane-inserted oligomer, the data were best fit to two lifetimes consisting either of 
two discrete exponentials or of a Lorentzian distribution and a discrete exponential. Only 
the major lifetime component (mole fraction > 80%) is shown here for both the 
monomer and the oligomer. A minor lifetime component that ranged between 1.7-4.3ns 
represents probes that are dynamically exposed to different environments within the 
protein. The half-widths of the Lorentzian distributions in the analyses (only for probe 
positions 401, 403, 437 and 491) were less than 2.4 ns. 
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Only the tip of D4 is exposed to the membrane core  
Collisional quenching of fluorescence is a direct method for determining whether 
the fluorophore and the quencher are co-localized because no quenching will be 
observed if the quencher cannot access and collide with the fluorophore (Crowley et al., 
1994; Hamman et al., 1998; Heuck and Johnson, 2002). For example, an NBD probe that 
is embedded in the hydrophobic core of the bilayer will be accessible to membrane-
restricted quenchers, such as an uncharged nitroxide moiety attached to the acyl chain of 
a phospholipid molecule, but will not be quenched by hydrophilic quenching agents such 
as iodide ions (I-) that are restricted to an aqueous solvent. We therefore used 12-doxyl-
PC, a phospholipid derivative with a nitroxide positioned near the center of the bilayer, 
to examine the location of each NBD probe in our mutants. 
We observed that only the probes exposed to a nonpolar environment (positions 
401, 403, 437 and 491) were quenched by membrane-restricted nitroxide moieties (Table 
1). Hence, it is clear that the loops at the tip of D4 are embedded in or exposed to the 
nonpolar membrane interior, and are not located at a nonpolar interface between two 
PFO monomers. 
To estimate the depth of D4 penetration into the membrane, we compared the 
extents of 12-doxyl-PC quenching of D4 probes with the quenching of two residues 
whose location in the bilayer is fixed and known. In the TM β-barrel formed by the 
oligomeric complex, residue 202 is located near the membrane surface in TMH1 and 
residue 303 is located near the center of the membrane in TMH2 (Shatursky et al., 
1999). Since the extent of quenching at positions 401, 403, 437 and 491 was similar to 
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that at position 202 (Table 1), and since we previously showed that the Trp residues in 
the highly-conserved 11-residue sequence of D4 were quenched by 5-doxyl-PC, but not 
by 12-doxyl-PC (Heuck et al., 2000), we conclude that the membrane-exposed probes in 
the loops at the tip of D4 are located close to the membrane surface. 
But the bulk of D4 is surrounded by water because probes with short lifetimes 
were strongly quenched by iodide ions (Table 2) and not by 12-doxyl-PC (Table 1). 
Interestingly, while two of the nitroxide-quenched probes (403 and 491) were not 
quenched by iodide ions, the other two (401 and 437) were weakly quenched by iodide 
ions (Table 2). The latter two NBD dyes are therefore most likely positioned near the 
interfacial region of the bilayer where they are dynamically and transiently exposed to 
iodide ions.  Thus, both the 12-doxyl-PC and iodide ion quenching data show that the tip 
of D4 is located at or near the lipid-aqueous interface. 
D4 orientation and contacts 
If D4 were to lie along the membrane surface or were to contact adjacent PFO 
monomers in the oligomeric complex, a probe positioned at a protein-membrane or 
protein-protein interface would be completely or largely inaccessible to aqueous 
collisional quenchers such as iodide ions (Heuck and Johnson, 2002). We therefore 
examined iodide ion quenching of probes at six water-exposed positions (397, 423, 433, 
442, 474 and 495) located all around the surface of the D4 β-sandwich (Figure 10) in the 
membrane-inserted oligomer. In each case, the NBD fluorescence was efficiently 
quenched (Table 2). Furthermore, since the probes on different D4 surfaces were 
quenched at similar rates (similar kq), the sizeable hydrated iodide ions (9 Å diameter) 
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Table 1. NBD exposure to the membrane interior 
Probe position         F / F0   
491     0.74 ± 0.07 
403                                           0.73 ± 0.05 
             401                           0.77 ± 0.02 
437                                           0.78 ± 0.03 
                         495     1.00 ± 0.01 
                                    433                                           1.05 ± 0.02 
455     1.00 ± 0.01 
                         397     1.08 ± 0.04 
   202 (near surface)   0.74 ± 0.06 
   303 (near center)              0.12 ± 0.02 
 
Quenching of NBD fluorescence by 12-doxyl-PC was measured and calculated as described under 
Experimental Procedures. The F/F0 values reported are an average of 4-8 independent experiments with 
the standard deviation indicated. F0 is the emission intensity of PFO inserted into a membrane lacking 12-
doxyl-PC and F is the emission intensity of an equivalent amount of PFO inserted into a membrane 
containing 12-doxyl-PC. To correlate the observed extents of D4 probe quenching with the depth of the 
probe in the bilayer under our experimental conditions, the quenching by 12-doxyl-PC of NBD probes 
located near the membrane surface (position 202 in TMH1) and the bilayer center (position 303 in TMH2) 
in the inserted PFO β-barrel are shown for comparison.  
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Table 2. NBD exposure to the aqueous milieu 
 Probe position                        kq (M-1 ns-1) 
  Water-soluble monomer        Membrane-inserted oligomer 
                      397                        7.1 ± 0.2           4.4 ± 0.1 
                      423                         3.2 ± 0.6        5.3 ± 0.1 
                                  433                             6.7 ± 0.7                                      3.0 ± 0.1   
            442            12.0 ± 0.3       2.7 ± 0.2                                        
           474                         7.0 ± 0.6                                      3.3 ± 0.1 
            495                           5.3 ± 0.5                                      4.1 ± 0.1 
                         491                         9.8 ± 0.5                                            0  
                            403                                5.8 ± 0.2                                            0 
                            401       9.5 ± 1.0                                      0.4 ± 0.1 
                         437                              12.3 ± 0.8                                      0.3 ± 0.1       
 
Collisional quenching of NBD fluorescence by iodide ions was measured as described under Experimental 
Procedures. The data were analyzed according to the Stern-Volmer equation: F0/F = 1 + kqτ0 [Q], where F0 
is the emission intensity of water-soluble or membrane-inserted PFO in the absence of quencher and F is 
the emission intensity in the presence of iodide ions at concentration [Q]. kq is the bimolecular quenching 
constant and τ0 is the primary fluorescence lifetime in the absence of quencher. kq was determined by a 
linear least-squares analysis of [(F0/F)-1]/τ0 at five different [I-] from at least three independent 
experiments as described under Experimental Procedures. 
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had similar access to all sides of D4. These data rule out the possibility that D4 lies at a 
small angle along the surface of the membrane in the oligomeric complex because iodide 
ions would not be able to move between a closely-juxtaposed D4 surface and the 
membrane to collide with dyes positioned at this interface. Instead, D4 must project out 
of the membrane surface. 
The iodide ion quenching data also show that D4 does not make extensive 
contact with adjacent monomers in the membrane-inserted oligomer because no probe is 
covered up and inaccessible to iodide ions. Since we have not placed probes over the 
entire surface of D4, and since each dye can be displaced slightly because of its short 
flexible tether, some small areas of contact between D4 and adjacent monomers may 
exist. However, the probe distribution in our experiments is sufficient to rule out major 
protein-protein interfaces involving D4. 
Each D4 probe is accessible to iodide ions in the water-soluble monomer, and the 
probes exposed to water in the membrane-inserted oligomer are also quenched by iodide 
ions as expected (Table 2). However, not surprisingly, the extents of NBD accessibility 
to iodide ions vary for the different probe locations. The reduction in quenching 
observed for all but one of the probes upon membrane insertion is expected because the 
presence of the membrane eliminates up to 50% of the routes by which iodide ions can 
approach and collide with each probe. But the monomeric kq values are differentially 
altered when PFO inserts into the membrane. These differences indicate that the 
conformation of D4 changes during pore formation. 
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D4 topography in the membrane-inserted oligomer 
The spectroscopic data reported here show directly and unambiguously that D4 is 
not embedded in and does not span the membrane in the fully-assembled and membrane-
inserted oligomer. Instead, only the hydrophobic loops at the tip of the D4 are exposed to 
the nonpolar interior of the bilayer (Figure 12). This includes the conserved 
undecapeptide loop at the tip of D4 that cannot be labeled with an extrinsic probe, but 
contains intrinsic Trp fluorophores. Three of the six D4 tryptophans are located in this 
loop, and we have previously shown that the Trps exposed to the membrane core are 
located near the surface (Heuck et al., 2000). Since the other three Trps are located near 
the middle of D4 and cannot reach the membrane surface, only the Trps in the 
undecapeptide loop are exposed to the membrane interior in the oligomeric complex. 
Furthermore, since all sides of the D4 surface are exposed both to water and to iodide 
ions, D4 projects out of the membrane surface and does not appear to be involved in 
extensive monomer-monomer interactions. These unexpected discoveries not only 
establish important aspects of D4 structure in the membrane-inserted oligomer, they also 
provide important insights into the mechanisms of membrane recognition and pore 
formation by PFO.   
Discussion 
Role of D4 in pore formation  
Since D4 is the first portion of the molecule observed to contact the membrane 
during pore formation (Heuck et al., 2000), and since CDCs do not function on 
membranes that lack cholesterol, D4 plays a critical role in PFO recognition of, and  
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Figure 12. D4 topography in the membrane-inserted oligomer. The combined 
fluorescence data position D4 on the bilayer surface as shown. Only the hydrophobic 
loops at the tip of D4 are exposed to the nonpolar membrane interior, while the bulk of 
D4 is exposed to the aqueous solvent and projects from the membrane surface. In this 
figure, only one monomer of the membrane-inserted oligomer is shown. As indicated in 
the figure, PFO undergoes a major conformational rearrangement during pore formation. 
However, the specifics of these conformational changes have yet to be determined, and 
hence much of PFO is shown here as an undefined gray cartoon. 
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targeting to, a cholesterol-containing membrane, presumably by mediating the 
cholesterol interaction required for toxin activity. The high proportion of solvent-
exposed hydrophobic residues in the loops at the tip of D4 in the water-soluble PFO 
monomer is consistent with such a role (Rossjohn et al., 1997), and our results strongly 
indicate that D4 interactions with the membrane are limited to those loops. Although 
cholesterol has been proposed to bind to sites on the D4 surface (Rossjohn et al., 1997), 
the nature of the putative interaction between PFO and cholesterol has yet to be defined 
experimentally. But our experimental data suggest that only a few residues of PFO are 
responsible for cholesterol, and hence membrane, recognition. Moreover, since the loops 
at the tip of D4 (Figure 10) represent some of the most conserved regions of CDC 
polypeptides, it seems likely that other CDCs recognize cholesterol in the same way. 
 After binding to the membrane surface, PFO oligomerizes to form a pre-pore 
complex (Heuck et al., 2000; Shepard et al., 2000; Hotze et al., 2001). Previous studies 
have suggested that D4 is a key participant in the oligomerization of different CDC 
molecules on the membrane surface (Iwamoto et al., 1990; Tweten et al., 1991; Gilbert 
et al., 1998; Weis and Palmer, 2001). If this were the case, then one would expect D4 to 
contact the surface(s) of adjacent CDC molecules and thereby create monomer-monomer 
interfaces that are inaccessible to solvent. Yet our data show that all sides of D4 except 
its tip are exposed to solvent and iodide ions in the membrane-inserted PFO oligomer 
(Table 2). Furthermore, the presence of a probe at these sites on the surface of D4 did 
not inhibit either oligomerization or pore formation by the toxin. The functional data 
therefore also indicate that monomer-monomer interactions do not include extensive 
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coverage of D4 surfaces. Although the data presented here do not rule out a transient 
contact of D4 with adjacent PFO monomers during oligomer assembly, it appears that 
D4 does not participate directly in the interactions that stabilize the toxin complex. 
Instead, D4 of PFO is conformationally coupled to D3 during membrane recognition and 
pore formation (Heuck et al., 2000).  Thus, the interaction of D4 with the membrane 
initiates a cascade of conformational changes within PFO that ultimately leads to pore 
formation. 
It is clear from Figure 12 that each PFO molecule undergoes major structural 
rearrangements during pore formation because D3 in the middle of the elongated 
monomeric protein must rotate its core β-sheet relative to D4 and then move to the 
membrane surface to insert both TMHs. Since D3 is linked to the top of D4 via domains 
1 and 2, and since the top of D4 is positioned above the membrane surface (Figure 12), a 
substantial amount of rotational and translational movement is required to bring the 
TMHs of D3 to the membrane surface. It therefore appears that D4 plays an additional 
role during pore formation by acting as a fulcrum or fixed axis of rotation around which 
the rest of the molecule can rotate and undergo the major conformational changes that 
are required during pore formation. Furthermore, the hydrophobic interactions between 
D4 and the nonpolar core of the membrane must provide sufficient stability to serve as a 
fixed foundation that can support the mechanical forces necessary for such structural 
changes, as well as facilitate the cooperative monomer-monomer interactions that enable 
the TMHs to penetrate the bilayer in a concerted fashion (Hotze et al., 2002).  
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D4 therefore performs multiple key functions during PFO pore formation, 
including its regulatory role in initiating the conversion of PFO from a water-soluble 
monomer to a membrane-inserted oligomer. All of these functions are accomplished 
with a minimal exposure of D4 to the membrane. Many other bacterial toxins generate 
pores of different types (β-sheets or α-helices) and sizes in membranes, but each faces 
the same mechanical problem: the regulated insertion of polypeptide into the bilayer. 
The data reported here therefore suggest a potential common principle for the 
mechanism of cytolytic action: only limited protein-membrane surface interactions are 
required to provide a base for the conformational changes required for pore formation. 
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CHAPTER IV 
MECHANISM OF PFO OLIGOMERIZATION 
AND INTERSUBUNIT β-SHEET ALIGNMENT* 
Introduction 
To date, PFO from C. perfringens is the only member of the CDC family to have 
its water-soluble structure solved at atomic resolution (Rossjohn et al., 1997), and no 
crystal structure of a membrane-inserted CDC oligomer has yet been determined. 
However, by covalently attaching a fluorescent probe to monitor the environment of 
various sites in the molecule and by using multiple independent fluorescence techniques 
to examine PFO structure, we have been able to identify several unique features of the 
CDC during its transition from a water-soluble monomer to a membrane-inserted 
oligomer (Heuck et al., 2001; Heuck and Johnson, 2002). Most notably, each monomer 
contributes two TMHs to the β-barrel formed by the oligomer (Shepard et al., 1998; 
Shatursky et al., 1999). In the monomer, these TMH sequences are each folded into three 
short α-helices, presumably to minimize premature entanglement of the two amphipathic 
sequences. Furthermore, the domain located at one end of the elongated PFO monomer, 
D4 (Figure 12), is responsible for the initial membrane recognition and binding, but only 
the tip of this domain is exposed to the nonpolar interior of the bilayer in the membrane-
inserted oligomer (Chapter III). Since D4 extends out of the membrane surface instead 
of being embedded in the bilayer, it is clear that major conformational changes are 
                                                 
*Reprinted with permission from Ramachandran, R., Tweten, R.K., and Johnson, A.E. (2004). Membrane-
dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and 
intersubunit β-strand alignment. Nat. Struct. Mol. Biol. 11, 697-705. 
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required to bring the TMHs in D3 of PFO to the membrane surface and then insert them 
into the membrane.  
We have recently shown that oligomerization precedes pore formation, and that 
the formation of an oligomeric prepore complex on the membrane surface is an 
obligatory precursor to the concerted insertion of the D3 TMHs into the membrane 
(Shepard et al., 2000; Hotze et al., 2001; Hotze et al., 2002; Heuck et al., 2003). The 
major structural transitions in PFO that accomplish pore formation are therefore 
regulated by oligomerization. What then controls oligomerization? Since PFO does not 
associate into multimeric aggregates even at high concentrations (10 mg ml–1) in 
aqueous solution, it would appear that whatever blocks PFO association disappears upon 
its stable binding to the target membrane. Furthermore, since no other proteins are 
involved in the spontaneous oligomerization and insertion of PFO into cholesterol-
containing membranes, the regulation of oligomerization is an intrinsic property of the 
PFO molecule itself. In addition, oligomerization must involve a mechanism for 
orienting adjacent monomers and ensuring that their TMHs are correctly aligned and in 
proper register with those of their neighbors to effect pore formation. 
To examine these control mechanisms, we have focused on four questions: What 
features in the three-dimensional structure of the monomer prevent its premature 
oligomerization in aqueous solution? How does membrane binding expose 
intermolecular interaction surfaces? What regions of the PFO molecule form the 
monomer-monomer interface in the oligomeric complex? How are the hydrogen-
bonding partners between neighboring monomers aligned to generate the oligomeric  
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Figure 13. PFO structural elements and mutations. Ribbon representation of the crystal 
structure of the water-soluble PFO monomer is shown in two orientations rotated 180o 
relative to each other. Polypeptide segments in D3 comprising the six short helices that 
unfold to form the two TM β-hairpins are labeled TMH1 (red) and TMH2 (green). The 
D3 segment comprising the loop and β5 (residues 325-337) that covers the edge of β4 in 
the monomer is shown in blue. Residues that were mutated in this study are shown in 
ball-and-stick representation and labeled accordingly. Tyr 181 mutants were 
characterized in a previous study (Hotze et al., 2002). 
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TM β-barrel? By using a combination of experimental approaches, we have identified 
the molecular changes in PFO conformation that occur upon membrane binding and 
show that these changes expose an otherwise-hidden interface required for monomer-
monomer interactions. These studies also suggest the mechanism by which β-strands in 
adjacent subunits are positioned correctly relative to each other during oligomerization. 
Results 
Experimental rationale  
 As noted above, the polypeptide sequences destined to form the TMHs are each 
folded into three short α-helices (Figure 13). But equally intriguing, the TMH sequences 
that ultimately contribute four β-strands to the β-barrel constitute extensions of an 
antiparallel β-sheet that forms the core of the folded protein (Shepard et al., 1998; 
Shatursky et al., 1999) (Figure 14). This observation led us to suggest that monomer-
monomer interactions in the oligomer may involve a backbone hydrogen bonding 
interaction between β-strands that extends from the TMHs into the core β-sheets of PFO 
(Shatursky et al., 1999). It would then be reasonable to assume that oligomerization 
could be prevented by blocking access of one edge of the core β-sheet in a monomer 
(these β-strands are designated β1, β2, β3, and β4 to differentiate the core sequences 
from the TMH sequences that form the ends of these β-hairpins in the inserted oligomer; 
Figure 14) to the opposite edge of the core β-sheet in the neighboring monomer. 
An examination of the crystal structure of the PFO monomer revealed that β1 in 
D3 is exposed to solvent and accessible for protein-protein interactions. However, β4 is  
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Figure 14. Conformational changes in D3. (A) Structure of the monomeric D3 core β-
sheet is shown on the left and a cartoon representation of its extension to form the 
aqueous-lipid interface in the oligomeric pore is depicted on the right (view from the 
pore center). The segment comprising the loop, β5 and the helix (residues 325-347) that 
covers β4 in the monomer has been deleted to allow visualization. All ribbon 
representations of the crystal structure were generated using MOLSCRIPT (Kraulis, 
1991) and rendered with Raster3D (Merritt and Bacon, 1997). (B) A schematic diagram 
of the arrangement of β-strands and α-helices in monomeric D3 with β-strands labeled 
β1-5 and segments color coded as above. 
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almost completely shielded from solvent by a stretch of polypeptide (residues 325–347) 
that is comprised of a loop, a short β-strand (termed β5) that hydrogen bonds to β4, and 
an amphipathic helix that packs across β4’s hydrophobic face (Figures 13, 14). This 
arrangement suggested that these structural elements evolved to cover β4 and thereby 
prevent its premature interaction with other PFO monomers in solution. We therefore 
initially focused our attention on these segments to ascertain whether they indeed played 
a role in controlling β4 exposure. 
β4 to β5 crosslinking inhibits oligomerization 
To determine whether a conformational rearrangement involving β5 is required 
for oligomerization and/or TM β-barrel insertion, we engineered a reversible disulfide 
bridge between β4 and β5. In earlier studies, we successfully employed this strategy to 
arrest PFO in the prepore complex by disulfide crosslinking TMH1 to D2 (Heuck et al., 
2000; Hotze et al., 2001). Thr319 in β4 and Val334 in β5 were replaced with cysteines 
based on the close proximity of their Cα atoms (Cα-Cα distance 4.5 Å) and their 
relatively high solvent accessibility. The double cysteine-substituted mutant was purified 
in the absence of reducing agent and tested for its ability to form pores in cholesterol-
containing membranes. In the absence of reducing agent, the toxin was unable to form 
pores in cholesterol-containing membranes. However, upon reduction of the disulfide 
bond with DTT, pore formation ensued, thereby indicating that β5 must move relative to 
β4 to achieve β-barrel insertion (Figure 15). 
To determine what stage of pore formation was blocked by the β4-β5 disulfide  
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Figure 15. Effect of β4-β5 disulfide-locking on pore formation. Time-dependent 
emission intensity profiles for liposome-encapsulated [Tb(DPA)3]3- (50 µM total lipid) 
when incubated with 50 nM of either pre-reduced (?) or unreduced (?) rPFO(T319C 
V334C) at 25oC in buffer D containing 5 mM EDTA. The release of liposome-
encapsulated [Tb(DPA)3]3- was monitored as described in Experimental Procedures. In 
the sample containing unreduced rPFO(T319C V334C), DTT was added to a final 
concentration of 3 mM 45 min after liposome addition (arrow). F0 is the initial intensity 
prior to toxin addition and F the intensity at time ‘t’. 
 
 
 
 77
bond, we systematically tested the ability of this disulfide-trapped PFO to bind, 
oligomerize and insert its TM β-sheet into the target membrane. As before (Heuck et al., 
2000), we monitored binding of the toxin molecule to the membrane surface by an 
increase in intrinsic D4 Trp fluorescence (Figure 16A) and D3 TMH insertion by the 
increase in emission intensity that accompanies the exposure of NBD, covalently 
attached to a single Cys substituted for Ala 215 in TMH1, to the hydrophobic interior of 
the membrane (Shepard et al., 1998) (Figure 16B). Quite remarkably, the β4-β5 
disulfide-locked PFO molecule retained its ability to bind to cholesterol-containing 
membranes at a rate nearly identical to that of the pre-reduced toxin (Figure 16A), 
thereby showing that the introduction of the disulfide bond in D3 did not detectably 
affect either the structure or the function of D4. However, the disulfide-locked mutant 
lacked the ability to insert into the membrane in the absence of reducing agent because 
no TMH1 insertion occurred under oxidizing conditions (Figure 16B). 
The ability of the disulfide-locked β4-β5 toxin to oligomerize in the absence of 
reducing agent was examined using agarose gel electrophoresis in the presence of SDS 
(SDS-AGE). We have previously demonstrated that both the prepore and the pore 
complexes of PFO are stable to SDS exposure, though the prepore complex is slightly 
more susceptible to subunit dissociation than is the fully-inserted oligomer (Shepard et 
al., 2000). However, the prepore complex can be stabilized by the addition of 
glutaraldehyde, an amine-to-amine crosslinking reagent, prior to SDS addition. The 
crosslinked prepore species exhibits mobility in SDS-AGE similar to that of the SDS-
resistant and fully-inserted pore complex.  
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Figure 16. Effect of β4-β5 disulfide-locking on membrane binding and TMH insertion. 
(A) Time-dependent Trp emission intensity for either pre-reduced (?) or unreduced (?) 
rPFO(T319C V334C) after addition of cholesterol-containing liposomes as described in 
Experimental Procedures. No DTT was added during the course of the experiment. (B) 
Time-dependent emission intensity for NBD attached to a membrane-facing cysteine 
residue at position 215 (A215C) in TMH1 was measured for either pre-reduced (?) or 
unreduced (?) rPFO(T319C V334C A215C-NBD) after addition of cholesterol-
containing liposomes as described in Methods. In the sample containing oxidized 
rPFO(T319C V334C A215C-NBD), DTT was added to a final concentration of 3 mM 
45 min after liposome addition (arrow). 
A 
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The disulfide-locked β4-β5 PFO derivative was therefore examined to determine 
whether it formed a prepore complex under oxidizing conditions. In the absence of the 
crosslinker, no band other than the monomer band was detected, even after incubating 
the toxin with cholesterol-containing membranes at 37oC for 30 min or more (Figure 17, 
lane 3). When 5 mM glutaraldehyde was added 2 min prior to the addition of SDS, small 
higher-molecular-mass species, presumably dimers and trimers, were observed in the gel 
(Figure 17, lane 4). However, none of these species corresponded to the much larger size 
of the prepore complex, thereby indicating that the disulfide-trapped β4-β5 mutant is 
unable to form a prepore complex. As expected, pre-reduction of the disulfide bond 
before addition of target membranes resulted in the mutant behaving very similarly to 
functional PFO by forming a large, SDS-resistant oligomer (Figure 17, lane 7). Thus, the 
presence of a disulfide-bond between β4 and β5 apparently prevents the structural 
rearrangement that exposes β4 for intermolecular interactions. Hence, we conclude that 
the disulfide-locked β4-β5 PFO derivative is trapped at the membrane-bound monomer 
stage of pore formation. 
Membrane binding alters PFO conformation near β4 
We previously showed the existence of a highly-coordinated interdomain 
communication network between D3 and D4 in PFO in which mutations in D3 
dramatically altered the kinetics of D4 binding to the membrane, even though D4 binds 
first to the membrane and the D3 mutation sites were spatially distant from D4 (Heuck et 
al., 2000). However, the extent and location of the conformational changes that occur 
upon D4 binding to the membrane were unknown. We therefore explored the possibility  
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Figure 17. Effect of β4-β5 disulfide-locking on oligomerization. Samples containing 
either unreduced (- DTT) or pre-reduced (+ DTT) rPFO(T319C V334C A215C-NBD) (1 
µM final) were incubated in the absence or presence of cholesterol-containing liposomes 
(1 mM total lipid) in buffer D for 30 min at 37oC as indicated. After the incubation, each 
sample was divided into two equal aliquots. One aliquot received 5 mM glutaraldehyde 
for 2 min at room temperature before the addition of urea (1 M final), while the other 
aliquot received buffer D instead of the crosslinker prior to urea addition. All samples 
were then dissolved in SDS sample buffer and electrophoresed as described in 
Experimental Procedures before visualization by NBD emission. M represents the 
monomer and O the oligomer. 
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that the membrane-dependent conformational changes in D3 involved β4. 
In the PFO monomer structure, residues 325–347 comprise the loop, β5 and the 
helix that form the ridges of a highly hydrophobic groove whose base consists primarily 
of residues from β4 (Figure 13). A conformational rearrangement to expose β4 would 
presumably also expose this base to solvent. Thus, to ascertain whether this putative 
rearrangement occurs, a fluorescent NBD probe was covalently attached to a single Cys 
substituted at position 322 in β4. This NBD-labeled PFO derivative exhibited pore-
forming activity comparable to the wild-type toxin (Appendix, Figure 33). 
NBD is an environmentally-sensitive fluorophore whose emission lifetime and 
intensity are highly sensitive to the presence of water (Crowley et al., 1993; Shepard et 
al., 1998; Heuck and Johnson, 2002). In a non-aqueous milieu, NBD has a fluorescence 
lifetime τ > 7 ns, while its lifetime in an aqueous environment is ~ 1 ns. As expected, the 
NBD dye at position 322 exhibited a high fluorescence lifetime (> 9 ns) in the 
monomeric form of the toxin, thereby demonstrating the dye’s burial in a hydrophobic 
environment. However, in the membrane-inserted form of the toxin, the NBD at position 
322 was in an aqueous environment (τ ~ 1 ns) (Table 3). These data clearly show that a 
major change in conformation occurs near β4 during pore formation. 
To gain temporal insight into this change in protein conformation, the rate of 
PFO binding to membranes was monitored by the increase in intrinsic D4 Trp emission 
intensity upon liposome addition and then compared to the rate of NBD emission 
intensity decrease when liposomes were added to rPFO(V322C-NBD). We have 
previously used similar kinetic measurements to demonstrate that the binding of D4 to  
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Table 3. Fluorescence lifetimes of rPFO(V322C-NBD) 
Species τ1 (ns)  width (ns) mol%  τ2 (ns)  mol% 
monomer    9.1       1.4    80     0.9     20 
oligomer    0.6      93     5.7      7 
The phase and modulation data were collected as described in Experimental Procedures and analyzed 
using GLOBALS UNLIMITED (University of Illinois) to compute the mole fraction of dyes in each 
environment. For the water-soluble monomer, the data were best fit (had the lowest χ2) to a Lorentzian 
distribution of long lifetimes and a discrete short lifetime, while the membrane-inserted oligomer data 
were best fit to two discrete lifetimes. In both cases, the major lifetime component (mole fraction > 80%) 
indicated that the probes were predominantly in either a hydrophobic (lifetime > 7 ns) or an aqueous 
environment (lifetime ~ 1 ns). The minor lifetime component presumably represents probes that are 
dynamically exposed to different environments. 
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the membrane surface precedes the insertion of NBD-labeled D3 TMHs into the bilayer 
(Heuck et al., 2000). But in this case, the rates of Trp and NBD intensity changes were 
nearly superimposable for rPFO(V322C-NBD) (Figure 18). This result demonstrates that 
the NBD-detected conformational rearrangement around β4 essentially coincides with 
PFO binding to the membrane surface and precedes TMH insertion into the bilayer. 
To determine directly whether the conformational change detected by the NBD 
probe in β4 is coupled to the movement of β5 relative to β4, a V322C mutation was 
introduced into the derivative that forms the β4-β5 disulfide bond, rPFO(T319C 
V334C), to yield rPFO(T319C V334C V322C). This protein was purified under non-
reducing conditions and then labeled with NBD to form rPFO(T319C V334C V322C-
NBD). When liposomes were added to a sample of this protein, the NBD emission 
intensity decreased by about 20% (Figure 19), much less than the 95% decrease 
observed with rPFO(V322C-NBD) (Figure 18). However, when DTT was then added to 
the disulfide-trapped sample, a dramatic decrease in NBD intensity was observed 
(Figure 19), similar to that seen in Figure 18. The origin of the initial 20% decrease may 
be due to a partial rotation of β5 relative to β4 and/or to a fraction of the rPFO(T319C 
V334C V322C-NBD) proteins that lacked disulfide bonds. Most important, the large 
fluorescence change observed upon addition of DTT demonstrates that the 
conformational change that exposes β4 requires β5 to move relative to β4, and hence 
that the membrane-dependent conformational change in D3 involves the rearrangement 
of β5 around β4.  
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Figure 18. D4-membrane interaction triggers a conformational change around β4 in D3. 
(A) Time-dependent emission intensities for Trp (?) and NBD (?) in rPFO(V322C-
NBD) (50 nM) were measured upon addition of 50 µM liposomes (55 mol% cholesterol, 
45 mol% POPC) as described in Experimental Procedures. (B) To allow direct 
comparison of the rate of change in Trp (?) and NBD (?) fluorescence, each intensity 
profile was normalized and plotted as the total fractional intensity change as a function 
of time. F0 represents the initial emission intensity before the addition of liposomes, F 
the intensity at time ‘t’, and Ff the intensity when t = 30 min. 
A 
B 
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Figure 19. Effect of β4-β5 disulfide-locking on the conformational change around β4. 
Time-dependent emission intensity for NBD in rPFO(T319C V334C V322C-NBD) (50 
nM) was measured upon addition of 50 µM liposomes as described in Experimental 
Procedures. DTT was added to a final concentration of 3 mM 30 min after liposome 
addition (arrow). 
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Loop flexibility is required for oligomerization 
Examination of the monomeric crystal structure revealed the presence of two 
glycines (Gly324, Gly325) at the junction of β4 and the loop leading to β5 (Figure 13). 
Interestingly, these glycines are conserved throughout the CDC family. To ascertain 
whether these glycines play an important functional/structural role in pore formation, we 
mutated both of these residues to valines. Valine, a bulky β-branched residue, restricts 
extensive movement around its peptide bond and hence may restrict any conformational 
rearrangement of the loop and movement of β5. The twin glycine mutant rPFO(G324V 
G325V) did not exhibit any pore-forming activity (Appendix, Figure 33), though it 
retained the ability to bind to cholesterol-containing membranes as detected by the 
increase in intrinsic tryptophan emission intensity (Appendix, Figure 34A).  
The absence of a prepore-sized oligomer after SDS-AGE analysis of 
rPFO(G324V G325V A215C-NBD) and visualization of bands by NBD fluorescence 
revealed that this mutant lacked the ability to form large oligomers on the membrane 
surface (Figure 20). Thus, valines at positions 324 and 325 apparently hinder the 
conformational rearrangement of the loop to β5 that is required to expose β4 for 
intermolecular interactions, consistent with the two glycines at the junction of β4 and the 
loop serving as a hinge around which to rotate the loop and β5 to expose β4. 
β1 of one monomer is adjacent to β4 of its neighbor 
 As noted above, it was previously suggested that monomer-monomer association 
would involve the hydrogen-bonding of β1 from one PFO molecule to β4 of the adjacent 
molecule in the oligomer (Shatursky et al., 1999). However, the monomer-monomer  
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Figure 20. Mutation of glycines at the end of β4 blocks oligomerization. SDS-AGE 
analysis of 2 µM rPFO(G324V G325V A215C-NBD) was carried out as described in 
Figure 17. Cholesterol-containing liposomes were added to a final concentration of 2 
mM. 
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interfacial surfaces have not been identified experimentally. To determine whether β1 in 
D3 of each monomer is in close proximity to, and therefore can interact with, β4 in D3 
of the neighboring monomer to generate an extended β-sheet in the oligomer (Figure 
13), we exploited the spectral properties of the fluorophore pyrene. The emission scan of 
monomeric pyrene reveals two peaks at 375 nm and 395 nm (λex = 345 nm), while a 
broad emission peak centered near 470 nm is observed when two pyrene dyes stack to 
form an ‘excited-state dimer’ or ‘excimer’ (Lehrer, 1997). Pyrene excimer formation is 
therefore only seen when two pyrene dyes are positioned adjacent to each other and are 
able to stack. As a result, this experimental approach constitutes an excellent method for 
detecting the close proximity of two sites labeled with pyrene dyes. For example, pyrene 
attached to a cysteine in β1 of one molecule can stack and form an excimer with a 
pyrene attached to a cysteine in β4 of another molecule only if the loop and β5 in the 
latter are rearranged from their original positions in the water-soluble monomer and if 
the β1 and β4 strands of neighboring monomers move adjacent to each other during 
oligomer formation. 
Two separate PFO derivatives were prepared by attaching a pyrene moiety to a 
single cysteine positioned either at residue 179 in β1 or, alternatively, residue 322 in β4 
(Figure 13).  Pyrene labeling at position 322 did not affect pore formation, while 
modification of the Cys at position 179 with any fluorophore blocked membrane 
insertion (Appendix, Figure 35A). Equimolar mixtures of rPFO(T179C-Pyr) and either 
rPFO or rPFO(V322C-Pyr) exhibited pore formation (Appendix, Figure 35A) but we 
could not unambiguously determine the extent of rPFO(T179C-Pyr) incorporation into 
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the inserted oligomers. However, rPFO(T179C-Pyr) formed pyrene fluorescence-
detected oligomers when mixed with an equivalent amount of rPFO, thereby 
demonstrating that rPFO(T179C-Pyr) was able to associate with functional PFO 
molecules into prepore complexes (Appendix, Figure 35B). Since rPFO(T179C-Pyr) 
associated with other PFO molecules to form oligomers, we were able to assess whether 
or not β1 and β4 were adjacent to each other in the prepore complex using excimer 
fluoresence. 
When an equimolar mixture of rPFO(T179C-Pyr) and rPFO(V322C-Pyr) was 
incubated with cholesterol-containing membranes, a strong pyrene excimer band was 
observed, thereby showing directly the close proximity of β1 in one monomer with β4 in 
the neighboring monomer in the oligomer (Figure 21). No excimer formation was 
observed when the mixture was incubated either in the absence of membranes or in the 
presence of cholesterol-free membranes (Figure 21A). In control experiments, no 
excimer fluorescence was seen in oligomers generated with only one of the two Pyr-
labeled mutants, indicating that pyrenes attached to the same position on adjacent PFO 
molecules are not close enough to stack (Figure 21B). Furthermore, no excimer 
formation was observed when rPFO(V322C-Pyr) was mixed with rPFO(Y181C-Pyr), 
thereby showing the expected strong dependency on the proximity of the pyrenes 
(Appendix, Figure 36). 
To determine whether the close proximity of β1 and β4 in neighboring 
monomers requires the membrane-dependent rearrangement of β5, the T179C and 
V322C mutations were introduced into derivatives that form the β4-β5 disulfide bond  
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Figure 21. Pyrene excimer formation detects β1 and β4 proximity in neighboring PFO. 
(A) Pyrene emission spectra for an equimolar mixture of rPFO(T179C-Pyr) and 
rPFO(V322C-Pyr) (100 nM total) in the presence of 100 µM lipid in cholesterol-
containing (solid line) or cholesterol-free POPC (dotted line) liposomes. (B) Pyrene 
emission spectra for rPFO(T179C-Pyr) (solid line) and rPFO(V322C-Pyr) (dotted line) 
(100 nM each) in the presence of cholesterol-containing liposomes (100 µM lipid). 
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and then the free Cys was labeled with pyrene to yield rPFO(T319C V334C T179C-Pyr) 
and rPFO(T319C V334C V322C-Pyr). Although the efficiency of Cys labeling at 
position 322 was reduced by the presence of the β4-β5 disulfide bond (see Experimental 
Procedures), these samples were sufficiently labeled to clearly resolve the issue. No 
excimer formation was observed when an equimolar mixture of rPFO(T319C V334C 
T179C-Pyr) and rPFO(T319C V334C V322C-Pyr) was incubated with cholesterol-
containing membranes under non-reducing conditions (Figure 22). However, upon 
reduction of the disulfide bond, excimer formation was observed (Figure 22), which 
indicates that the membrane binding-dependent rearrangement of β5 exposes β4 and 
allows the close juxtaposition of β1 and β4 in neighboring monomers. (Less excimer 
formation was seen in Figure 22A than in Figure 21A because of the lower pyrene 
content in the disulfide-linked sample.) These data therefore show that β1 in one 
monomer is in close proximity to β4 in the neighboring monomer where they can 
participate in hydrogen-bonding interactions to generate the oligomeric β-sheet (Figures 
14, 21, 22). The β1 and β4 edges of the core PFO β-sheet therefore constitute important 
interfacial surfaces between two monomers in the oligomeric complex. 
Aromatic residues align intersubunit β-strands 
 A previous study showed that the mutation of Tyr181 in β1 to a residue other 
than Phe dramatically inhibited the pore-forming activity of the toxin by preventing the 
insertion of the TM β-barrel and reducing the stability of the prepore complex (Hotze et 
al., 2002). The strict requirement for an aromatic residue at position 181 suggests that it 
is involved in a π-stacking interaction with an aromatic residue of the neighboring  
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Figure 22. Excimer formation in the presence of the β4-β5 disulfide lock. (A) Pyrene 
emission spectra for an equimolar mixture of rPFO(T319C V334C T179C-Pyr) and 
rPFO(T319C V334C V322C-Pyr) (100 nM total) incubated with cholesterol-containing 
liposomes (100 µM lipid) in the presence (solid line) and absence (dotted line) of 3 mM 
DTT. (B) Time-dependent pyrene excimer emission intensity for an equimolar mixture 
of rPFO(T319C V334C T179C-Pyr) and rPFO(T319C V334C V322C-Pyr) was 
measured as described in Experimental Procedures for either a pre-reduced (?) or an 
unreduced (?) sample. In the sample containing the oxidized protein, DTT was added to 
a final concentration of 3 mM 30 min after liposome addition (arrow).   
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Figure 23. F318A mutation blocks pore formation but not membrane binding. (A) Time-
dependent emission intensities for liposome-encapsulated [Tb(DPA)3]3- (50 µM total 
lipid) were measured at 25oC as described in Experimental Procedures after the addition 
of 50 nM rPFO(F318A) (?), rPFO(F318Y) (?), or rPFO (?). (B) Time-dependent Trp 
emission intensity was measured after addition of cholesterol-containing liposomes (50 
µM) to 50 nM rPFO(F318A) (?) and rPFO(F318Y) (?) as described in Experimental 
Procedures. 
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monomer to stabilize the intersubunit β-strand association in the prepore complex and/or 
promote the insertion of the β-barrel into the membrane bilayer. Examination of the PFO 
structure revealed that β1 and β4 each contained only a single aromatic residue: Tyr181 
and Phe318, respectively (Rossjohn et al., 1997). Furthermore, each of the 11 sequenced 
CDCs has a Tyr at the equivalent of position 181, while 8 of the 11 have a Phe at 318. 
 Substitution of Phe318 with Ala, Cys or Trp prevented pore formation, while a 
F318Y substitution did not alter pore formation (Figure 23A; data for F318C and F318W 
not shown). However, the F318A mutant was able to bind cholesterol-containing 
membranes at a rate similar to that of the F318Y mutant, as determined by the increase 
in intrinsic Trp fluorescence (Figure 23B). Moreover, like the Y181A mutant (Hotze et 
al., 2002), the F318A mutant was able to form a prepore complex on the membrane 
surface (Figure 24A). But little insertion of the TM β-sheet of rPFO(F318A A215C-
NBD) was observed by increases in either NBD lifetime (Table 4) or intensity (Figure 
24B), as expected by the lack of pore formation. When a 4-fold excess of unmodified 
and functional rPFO was mixed with rPFO(F318A A215C-NBD), the mutant toxin 
molecules were able to insert their TMHs into the bilayer (Table 4, Figure 24B). This 
effect is similar to that observed earlier with the Y181A mutant (Hotze et al., 2002), 
where the cooperative nature of the pore formation process allows wild-type PFO 
molecules to overcome whatever barrier is created by the F318A mutation. Thus, the 
comparable mutations at Tyr181 and Phe318 were phenotypically identical in terms of 
disrupting late stages of PFO pore formation. 
The fact that pore formation occurred only if the small aromatic side chains of  
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Figure 24. F318A mutation blocks TMH insertion but not prepore formation. (A) SDS-
AGE analysis of rPFO(F318A, A215C-NBD) in the presence or absence of liposomes 
and in the presence or absence of glutaraldehyde as indicated. (B) NBD emission spectra 
for 20 nM rPFO(F318A, A215C-NBD) in the absence of liposomes (dashed line), in the 
presence of 80 nM unlabeled rPFO(F318A, A215C)  and cholesterol-containing 
liposomes (dotted line), and in the presence of 80 nM rPFO and cholesterol-containing 
liposomes (solid line). The toxin was incubated with liposomes (100 µM total lipid) in 
buffer D at 37oC for 30 min before cooling to 25oC for spectral measurements as 
described in Experimental Procedures. 
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Table 4. Fluorescence lifetimes of rPFO(F318A A215C-NBD) 
Species    τ1 (ns)  mol%  τ2 (ns)  mol% 
monomer       1.2    87     4.2     13 
oligomer       1.3    85     7.7     15 
oligomer formed with 4X rPFO    8.7    69     0.9     31 
Lifetimes were measured and the data analyzed as described in Table 3. In all cases, the data were best fit 
to two discrete lifetimes. 
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Tyr or Phe were located at positions 181 and 318 is consistent with the idea that a 
sterically-restricted π-stacking interaction between the two residues is required for PFO 
oligomer insertion into the bilayer. One way to address this possibility experimentally is 
to shift each aromatic residue two positions along its β-strand so that the side chains 
would be on the same side of the β-sheet as in wild-type PFO. If the stacking of the 
aromatic rings is important for function, then it is possible that this derivative would be 
active because the locations of the rings relative to each other would be unchanged.  
We therefore prepared a quadruple mutant of rPFO(Y181A F318A T179Y 
A320F) (iv in Figure 25), as well as mutants that contained only one altered aromatic or 
no aromatics as controls (i, ii, and iii in Figure 25). All of these derivatives were able to 
form large oligomeric complexes on cholesterol-containing membranes (Figure 26A). 
However, only one, the quadruple mutant iv, was functionally active. While the control 
samples were not active or were barely active in pore formation, iv formed pores at a 
rate faster than that of unmodified rPFO (Figure 26B). The increased rate of pore 
formation by iv is explained by the fact that iv binds to membranes at a much higher rate 
than does its parent toxin, rPFO (Appendix, Figure 34B). This result shows that the 
relative positioning of the two aromatic rings in β1 and β4 is critical for PFO pore 
formation. Thus, it appears that the stacking of Tyr181 and Phe318 between neighboring 
monomers not only helps to stabilize the prepore complex, but also serves to align the 
adjacent β1 and β4 strands in the proper register to effect insertion of the TM β-barrel. A 
similar stacking phenomenon has been proposed to stabilize the assembly of β-sheet-rich 
amyloid fibrils containing short aromatic-containing peptides (Gazit, 2002).  
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Figure 25. Alignment of aromatic residues in β1 and β4 is critical for pore formation. 
Aromatic residue positioning in β1 and β4 of rPFO and mutants labeled i through iv. 
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Figure 26. Analysis of mutants i through iv. (A) SDS-AGE analysis of oligomer 
formation by rPFO and i–iv as in Figure 25. All samples received glutaraldehyde and 
oligomers were detected using Coomassie Blue staining. (B) Time-dependent detection 
of pore formation by rPFO and i–iv as in Figure 25. 
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Discussion 
Mechanism of PFO oligomerization and intersubunit β-sheet alignment 
Four questions critical to our understanding of how PFO oligomerizes and forms 
pores were posed, and the answers to these questions have here been determined 
experimentally using a wide variety of approaches and techniques. The monomer-
monomer interface in the PFO oligomer is formed when the β1 strand in one subunit 
associates, presumably via hydrogen bonding, with the β4 strand in a second subunit 
(Figures 21, 22). Premature association of PFO molecules (i.e., prior to their binding to 
an appropriate membrane surface) is prevented by the presence of β5, a short stretch of 
polypeptide that hydrogen bonds to β4 in the monomer and thereby prevents its 
interaction with the β1 strand of a second subunit (Figures 15-17). The binding of PFO 
D4 to the membrane surface elicits a conformational change in D3 that rotates β5 away 
from β4 and thereby exposes β4 to the aqueous medium where it can associate with the 
always-exposed β1 strand of another PFO molecule to initiate or promote 
oligomerization (Figures 18, 19). The β-strands of neighboring monomers then appear to 
be aligned in the proper register relative to each other by the aromatic π-electron 
stacking of the Tyr and Phe residues in β1 and β4. Since no pore formation is observed 
with mutants lacking Phe or Tyr at positions 181 and 318, this previously-unrecognized 
stacking interaction is an essential step in the mechanism of PFO pore formation 
(Figures 23-26). The data obtained here with various spectroscopic approaches have 
therefore provided significant insight into the molecular mechanisms that regulate the 
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oligomerization of PFO (and probably other CDCs) and the initiation of pore formation. 
When these results are combined with those of our previous studies, the sequence 
of events that control and/or effect the transition of PFO from one functional state to the 
next are, for the most part, clearly delineated. Upon secretion from C. perfringens, PFO 
folds into a stable tertiary structure that avoids or minimizes the potential entanglement 
of the two amphipathic TMHs prior to membrane binding by having each adopt a stable 
α-helical secondary structure in the monomer (Rossjohn et al., 1997; Shepard et al., 
1998; Shatursky et al., 1999). The premature association of PFO monomers in solution is 
prevented by the hydrogen bonding of β5 to β4 that obscures the subunit-subunit 
interface (Figure 27A). When D4 recognizes a cholesterol-containing membrane surface 
(Heuck et al., 2000), only the polypeptide loops at the tip of D4 are inserted into the 
nonpolar core of the bilayer (Ramachandran et al., 2002) and a conformational change is 
triggered that extends more than 70 Å through the elongated PFO monomer to rotate the 
loop containing β5 around the Gly-Gly swivel at the end of β4 (Figure 20) and thereby 
expose the edge of β4 to the solvent (Figure 27B). Two-dimensional diffusion on the 
membrane surface then leads to productive collisions between PFO monomers that result 
in β1 in one monomer hydrogen bonding to the now-exposed β4 in a second PFO 
molecule (Figure 27C). Continued association of monomers with the original PFO dimer 
results in an oligomer (Heuck et al., 2000; Shepard et al., 2000; Hotze et al., 2001) 
containing up to 50 PFO molecules in a circular prepore complex (Oloffson et al., 1993; 
Hotze et al., 2001). Upon association, β1 and β4 in neighboring subunits move parallel 
to each other until Tyr181 in β1 of one subunit stacks on Phe318 of β4 in the adjacent  
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Figure 27. Mechanism of oligomerization and intermolecular β-sheet formation. (A-D) 
A schematic model of the conformational changes required for monomer-monomer 
interactions and β-barrel formation in D3 of PFO is depicted and described in the text. 
Stage i represents the binding of PFO to the membrane surface via D4 (not shown in the 
figure), stage ii the oligomerization of PFO monomers on the membrane surface, and 
stage iii the insertion of the oligomer TMHs into the membrane. Aromatic residues in β1 
and β4 of neighboring monomers are represented by clear rectangles in a and b; in c and 
d, these rectangles indicate stacked aromatic residues. In (D), the view is from the center 
of the aqueous pore. The polypeptide segments are color-coded as in Figure 13. 
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subunit to fix the position of the two β-strands in the proper register and at the proper 
angle relative to the plane of the membrane (Figure 27C). The hydrogen bonding 
between the now-aligned β1 and β4 strands in adjacent monomers in the prepore 
complex then causes the unfolding of the TMH helices in each subunit and nucleates the 
edgewise association of the elongated β-hairpins into an extended β-sheet, followed by 
(or coincident with) the cooperative (Hotze et al., 2002) insertion of the hydrogen-
bonded TMHs into the membrane to form the pore (Heuck et al., 2003) (Figure 27D). 
The order of the steps involved in β1-β4 alignment and TMH unfolding (Figure 
27D) has not been determined experimentally, and may actually be reversed. We 
arbitrarily placed alignment ahead of unfolding above only because β1 and β4 seem 
more likely to orient themselves relative to each other when there are fewer 
opportunities to form hydrogen bonds between the strands. However, the TMHs are not 
exposed to the nonpolar interior of the bilayer in the membrane-bound prepore complex 
(Heuck et al., 2003). 
The data of Figures 18 and 19 provide compelling evidence for the coupling of 
the conformation of D4 with that of D3 to coordinate PFO binding to the membrane with 
PFO oligomerization. We had previously shown that the spatially-distant D3 and D4 
conformations were coupled (Heuck et al., 2000), but the functional ramifications of that 
structural linkage were not clear until now. The conformational changes elicited by PFO 
binding to the membrane extend throughout most, if not all, of the PFO molecule and 
thereby demonstrate the delicate balance of forces that maintain PFO in its water-soluble 
monomeric conformation, poised to initiate the above structural changes that lead to the 
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stable SDS-resistant membrane-inserted oligomer.  
A very effective and efficient mechanism appears to have evolved to ensure that 
a peptide bond hydrogen in the extended β1 strand of one PFO molecule makes a 
hydrogen bond with the correct peptide bond carbonyl oxygen in the extended β4 strand 
of the adjacent PFO in the oligomer, thereby ensuring that the TMHs are aligned at the 
proper angle to insert into the membrane (Figures 23-26). The association of aromatic π-
electron systems provides sufficient free energy to stably bind Y181 to F318, and 
thereby position β1 and β4 next to each other in the proper register. The same stacking 
phenomenon led to the stable association of pyrene dyes attached to β1 and β4 (Figures 
21, 22), and also stabilizes RNA and DNA structures, and the assembly of β-sheet-rich 
amyloid fibrils containing short aromatic-containing peptides (Gazit, 2002). 
The coupling of membrane binding to the unmasking of the oligomerization site 
on PFO may be common to all or most cytolysins. A comparison of the crystal structures 
of membrane-embedded S. aureus α-HL (Song et al., 1996) and the water-soluble 
monomer of its LukF homologue (Olson et al., 1999) suggests that the N-terminus of the 
αHL is folded into an interface surface in the monomer and interacts with the core β-
sheet in the neighboring subunit in the heptamer (Montoya and Gouaux, 2003). 
Although the kinetics of membrane binding and N-terminus rearrangement have not 
been measured for αHL, it is reasonable to presume that αHL binding to the membrane 
surface elicits a conformational change that promotes heptamer formation and 
stabilization. 
The strategy used by PFO, and presumably by all other CDCs, to prevent 
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premature oligomerization in solution is not uncommon among β-sheet-containing 
proteins. A recent study of β-sheet structures in native proteins found that edge-to-edge 
association of β-strands of individual protein molecules was frequently prevented either 
by sterically covering a β-strand edge or by hydrogen-bonding a short stretch of 
polypeptide to the exposed β-strand edge similar to that seen with β5 in PFO 
(Richardson and Richardson, 2002). Interestingly, PFO employs both of these 
approaches to prevent premature oligomerization (Figure 13). 
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CHAPTER V 
TOPOGRAPHY OF MEMBRANE-BOUND PFO  
AT DIFFERENT STAGES OF PORE FORMATION 
Introduction 
The transition of the water-soluble PFO monomer into a membrane-inserted 
oligomer involves extensive changes in protein conformation that have been the focal 
point of research among investigators during the past few years. Using the crystal 
structure of the PFO monomer (Rossjohn et al., 1997), a repertoire of site-specifically 
mutagenized PFO derivatives, and multiple independent fluorescence techniques, several 
structural states and rearrangements have been identified along with various protein-lipid 
and protein-protein interactions that mediate the conformational changes. D4, located at 
one end of the elongated PFO monomer (Figure 28), is responsible for membrane 
recognition and initial binding (Heuck et al., 2000), but only the tip of this domain is 
embedded in the nonpolar interior of the bilayer (Ramachandran et al., 2002). D4-lipid 
interactions trigger conformational changes in the spatially-distant D3 that expose a 
previously-hidden interface for oligomerization and hence prepore complex formation 
(Ramachandran et al., 2004). Two sets of three short α-helices in D3 then undergo an α-
helix-to-β-sheet transition to create two TM β-hairpins, TMH1 and TMH2, per monomer 
that are then inserted into the bilayer (Shepard et al., 1998; Shatursky et al., 1999). This 
insertion also occurs in stages since the TMHs are not exposed to the nonpolar core of 
the bilayer in the prepore complex (Heuck et al., 2003). The conversion of PFO from a  
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Figure 28. PFO dimensions and locations of mutations. Ribbon representation of the 
crystal structure of monomeric water-soluble PFO (Rossjohn et al., 1997) is shown. 
Either E167 in D1 or A215 in D3 was substituted with a Cys for BODIPY-labeling. 
Locations of the two residues substituted with Cys that introduce an intramolecular 
disulfide bond are shown by a “cross-bar”, while the location of the F318A mutation is 
represented by a “star”.  The image was generated using MOLSCRIPT (Kraulis, 1991). 
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water-soluble monomer to a membrane-inserted oligomer therefore involves the 
structural coupling of D3 and D4 (Heuck et al., 2000; Ramachandran et al., 2004). 
The crystallized PFO monomer is elongated in shape and measures about 115 Å 
in its longest dimension (Rossjohn et al., 1997) (Figure 28). Since D4 remains peripheral 
to the bilayer throughout pore formation and is oriented with its long axis nearly 
perpendicular to it (Ramachandran et al., 2002), PFO may bind to the target membrane 
surface in an ‘end-on’ orientation (Figure 29i) and interact with the membrane only via 
the hydrophobic loops of D4. If this were true, the polypeptide stretches in D3 that 
eventually form TMHs 1 and 2 would be located > 40 Å above the membrane surface 
prior to insertion (Figure 28).  Major conformational changes would then be necessary to 
bring the TMHs in D3 to the bilayer surface for insertion. 
Consistent with the above idea, a recent atomic force microscopy (AFM) study 
reported a significant difference in the height above the membrane surface of the prepore 
complex (113 ± 5 Å) and the inserted pore complex (73 ± 5 Å) (Czajkowsky et al., 
2004). This study also indicated, consistent with earlier work (Heuck et al., 2003), that 
the polypeptide segments destined to form the TMHs are not in contact with the bilayer 
at the prepore stage of pore formation. The AFM data therefore suggest that the PFO 
molecule undergoes a ‘vertical collapse’ on the membrane surface during the prepore-to-
pore transition as the TMHs are inserted into the membrane bilayer. 
While the AFM study revealed the existence of a major structural reorganization 
of PFO during the prepore-to-pore transition, the domain specificity of the 
rearrangement was not addressed. Moreover, the AFM study did not examine the initial  
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Figure 29. Conceivable orientations of PFO on the membrane surface. Cartoons of 
potential domain rearrangements as PFO first binds to the membrane and then 
oligomerizes before forming the inserted pore complex. i represents an ‘end-on’ 
orientation of the membrane-bound PFO monomer, while ii represents a ‘flat’ 
orientation. 
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topography of PFO immediately after binding to the membrane, prior to oligomerization. 
Hence, in this study, we sought to provide specific information about the nature of the 
PFO-membrane complex before oligomerization, as well as to monitor the topography of 
two PFO domains above the membrane surface at every step of the pore formation 
process. Specifically, what is the orientation of the PFO molecule when it first binds to 
the membrane surface? Does it bind to the membrane surface in an “end-on” or a “flat” 
orientation (Figure 29i or 29ii)? What domain-specific conformational changes occur 
during the transition between the membrane-bound monomer and the membrane-bound 
oligomer? How far from the membrane surface are the D3 TMHs prior to insertion? 
Fluorescence resonance energy transfer (FRET) measurements between the 
membrane surface and different domains of the PFO molecule at each stage of pore 
formation reveal that the PFO molecule is initially anchored in an ‘end-on’ orientation, 
with the long axis of the molecule nearly perpendicular to the plane of the bilayer. 
Monomer-monomer association and subsequent prepore complex formation does not 
greatly alter the height of the molecule relative to the membrane surface. Also, the D3 
TMHs are located are far above the membrane surface prior to insertion. But while 
major changes in the overall topography of the PFO molecule occur during the prepore-
to-pore transition of the oligomer, D1 still is located farthest from the membrane surface. 
Results 
Experimental rationale and design  
D4 is responsible for membrane recognition and the initial binding of PFO to the 
membrane bilayer (Heuck et al., 2000). Furthermore, D4 projects nearly perpendicularly 
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from the bilayer surface in the membrane-inserted PFO oligomer (Ramachandran et al., 
2002). These results are consistent with the notion that the water-soluble monomer 
arrives ‘end-on’ at the membrane surface and is initially anchored by D4 to the 
membrane with its long axis perpendicular to the plane of the membrane bilayer as 
depicted in Figure 29i. However, since the TMHs of PFO originate from the spatially-
distant D3, it is also possible that PFO might bind to the membrane so that D3 is 
positioned close to the membrane surface as depicted in Figure 29ii. Moreover, these 
models are not mutually exclusive because there is a distinct possibility that PFO 
initially anchors itself to the membrane in an ‘end-on’ orientation and then relatively 
quickly undergoes conformational changes that bring D3 into close proximity with the 
membrane surface for TMH insertion. Hence, to identify the conformational changes 
associated with pore formation into a membrane, we have directly determined the 
locations of D1 and D3 relative to the membrane surface at different stages of pore 
formation using FRET. 
FRET is an excellent method for identifying conformations and detecting 
conformational changes, as well as for measuring the magnitude of a conformational 
change within a distance range of 20-100 Å (Stryer, 1978). The typical FRET 
experiment requires two fluorescent molecules, a ‘donor’ (D) and an ‘acceptor’ (A), that 
are each located at a specific site in the same or different molecule(s). After excitation 
by the absorption of a photon, an excited D can non-radiatively transfer its excited-state 
energy to an appropriate A under certain circumstances. The efficiency of this energy 
transfer depends primarily upon the extent of the overlap between D’s emission and A’s 
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absorption spectra, the relative orientation of the D and A transition dipoles, and the 
distance between D and A. Donor emission intensity is reduced by FRET and the 
magnitude of this decrease is used to measure the extent of energy transfer.  FRET has 
been primarily used to measure point-to-point distances between two sites within a 
molecule or between two molecules (e.g. Johnson et al., 1982; Watson et al., 1995; 
Woolhead et al., 2004). 
A variation of the FRET technique allows one to measure the distance between 
two parallel planes. Such an experimental situation is created when a protein binds to a 
membrane surface. The membrane or vesicle surface therefore provides one plane, and 
for large vesicles with low curvature, this surface approximates an infinite plane. If all 
bound proteins adopt the same conformation, then a site (amino acid or a probe) on the 
protein constitutes the second infinite plane because the site will be located at the same 
height above the membrane for all proteins. Covalently attaching a D dye (here, 
BODIPY) to a single site in each protein molecule and then binding these proteins to a 
vesicle that contains a phospholipid with a charged A dye covalently attached to the 
headgroup (here, Rh-PE) to localize it at the surface therefore allows one to determine 
the height of D above the membrane. Since the Rh-PE molecules freely diffuse laterally 
in the membrane, quantification of the height requires using analytical expressions that 
assume a random and uniform distribution of A on the membrane surface. We have used 
this approach to determine the locations above the membrane surface, of the active sites 
of several membrane-bound blood coagulation enzymes, and to quantify coagulation 
cofactor-dependent alterations in those locations that appear to be functionally important 
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(Isaacs et al., 1986; Husten et al., 1987; Lu et al., 1989; Armstrong et al., 1990; 
Mutucumarana et al., 1992; McCallum et al., 1996; McCallum et al., 1997; 
Yegneswaran et al., 1997; Yegneswaran et al., 1999). 
PFO derivatives trapped at different stages of pore formation 
We have previously shown that an intramolecular disulfide bond engineered 
between Cys residues substituted at positions 319 (T319C) and 334 (V334C) in D3 traps 
PFO as a membrane-bound monomer in the absence of reducing agent (Ramachandran 
et al., 2004). Hereafter, rPFO(T319C V334C) will be referred to as rPFODS to denote the 
presence of the intramolecular disulfide bond. To determine the locations of D1 and D3 
relative to the membrane surface at the membrane-bound monomer stage of pore 
formation, we introduced into rPFODS a third Cys residue located either at position 167 
in D1 or position 215 in D3 TMH1 (Figure 28) and labeled this third free Cys with 
BODIPY to yield rPFODS(E167C-BODIPY) or rPFODS(A215C-BODIPY), respectively. 
In the presence of the reducing agent DTT, these intramolecularly disulfide-bonded 
molecules readily formed pores in cholesterol-containing membranes, and hence were 
fully functional after being released to accomplish the monomer-to-oligomer transition 
by removing the disulfide bond. 
To block PFO insertion at the prepore stage of pore formation, we used a point 
mutant in PFO (F318A) that prevented TMH insertion and thereby arrested the PFO 
oligomer in the prepore state (Ramachandran et al., 2004). In the F318A background, a 
single Cys was introduced at either position 167 or at position 215 in two separate rPFO 
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mutants and labeled with BODIPY to yield rPFO(F318A, E167C-BODIPY) and 
rPFO(F318A, A215C-BODIPY), respectively. 
Spectral properties of BODIPY-labeled rPFO derivatives 
 The quantum yields of rPFO derivatives labeled at either position 167 or position 
215 were determined experimentally to be 0.65 and 0.74, respectively, using soluble, 
unreduced rPFODS(E167C-BODIPY) and rPFODS(A215C-BODIPY). Since the 
fluorescence lifetimes of the BODIPY-labeled rPFO derivatives (5.0 ± 0.2 ns) did not 
change appreciably after incubation with cholesterol-containing membranes (data not 
shown), we conclude that the quantum yields of the BODIPY dyes attached to these 
positions do not change as the protein progresses through all stages of pore formation. 
 Interestingly, however, significant differences were observed in the steady-state 
anisotropy values of the BODIPY dye attached to position 167 in D1 of rPFO 
derivatives trapped at different stages of pore formation. Anisotropy values of 0.20, 0.15, 
and 0.12 were determined for oxidized rPFODS(E167C-BODIPY), rPFO(F318A E167C-
BODIPY), and reduced rPFODS(E167C-BODIPY), respectively, after incubation with 
cholesterol-containing membranes (see below). These data indicate that the rotational 
freedom of the BODIPY dye in D1 increases during pore formation, though the exact 
nature of this change remains undefined. In contrast, very little change was seen in the 
anisotropy of the BODIPY dye (0.21 ± 0.01) attached to position 215 in D3 at different 
stages of pore formation (see below). Hence, the rotational freedom of the BODIPY dye 
in D3 is essentially the same before and after membrane insertion. 
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Topography of PFO as a membrane-bound monomer 
To determine whether the PFO monomer initially binds to the membrane in an 
‘end-on’ or a ‘flat’ orientation (Figure 29i or 29ii), we measured FRET between Rh-PE 
molecules located at the membrane surface and rPFODS(E167C-BODIPY) that was 
trapped in the monomeric state after binding to the membrane. When this mutant was 
bound to Rh-PE-containing membranes in the absence of DTT, essentially no energy 
transfer was observed from position 167 in D1 to Rh-PE at the membrane surface even 
at high acceptor density (Figure 30A), thereby demonstrating that the PFO molecule is 
stably bound to the membrane surface as a monomer in an ‘end-on’ orientation (Figure 
29i). A ‘flat’ orientation (Figure 29ii) would have positioned the BODIPY dye in D1 
much closer to the membrane surface and significant energy transfer would have been 
observed. The distance of closest approach or height of the BODIPY probe above the 
membrane surface, L, must therefore be >110 Å.  
We then determined the location of the D3 TMH segments in membrane-bound 
monomeric PFO relative to the membrane surface. Data from collisional quenching 
experiments indicate that the TMH residues do not come into contact with the 
hydrophobic core of the bilayer even at the prepore stage of pore formation (Heuck et 
al., 2003; Czajkowsky et al., 2004). Yet very little is known about the positioning of 
these TMH segments relative to the membrane surface prior to their insertion into the 
bilayer. To ascertain the location of the TMH segments prior to membrane insertion, we 
chose a location (A215C) that would ultimately place the donor probe on the 
hydrophobic side of the TM β-barrel in the inserted pore complex. We then measured  
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Figure 30. Dependence of energy transfer upon acceptor density. QD/QDA values for 
energy transfer between either D1 (A) or D3 (B) of each stage-trapped mutant and the 
membrane surface at 3 different acceptor densities (σ). The lines shown are the best-fit 
lines determined by linear regression as described under Experimental Procedures and 
have been required to go through position (0, 1). 
 
 
A 
B 
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the extent of energy transfer between unreduced rPFODS(A215C-BODIPY) and Rh-PE. 
Significant energy transfer was observed for rPFODS(A215C-BODIPY) (Figure 30B), 
and the height of this residue in TMH1 above the membrane surface was determined to 
be 72 ± 1 Å in the membrane-bound monomer. Since QD/QDA was found to be directly 
proportional to σR02 over a range of σ values, as indicated by linear plots in Figures 30A 
and 30B, the approximation of Dewey and Hammes (1980) (eq. 6) can be used to 
calculate L. Thus, the TMHs are located far from the membrane surface at the initial 
stage of pore formation. 
Topography of PFO in the prepore complex 
To ascertain whether the topography of the membrane-bound PFO monomer 
changes significantly upon association with other monomers to form a prepore complex, 
we next measured the extent of energy transfer between Rh-PE and rPFO(F318A 
E167C-BODIPY) trapped at the prepore stage of pore formation. In this case, a small 
amount of energy transfer was observed (Figure 30A), indicating that the location and/or 
orientation of D1 and its probe relative to the membrane surface had changed somewhat 
upon forming an oligomeric prepore complex. The increased FRET efficiency could also 
be explained wholly or in part either by a translational movement by D1 towards the 
membrane surface or by a rotation of D1 and the BODIPY probe relative to the 
membrane surface that changes κ2 (see below). The possibility of a rotational movement 
is supported by the fact that the rotational freedom of the donor dye significantly 
increases (anisotropy decreases from 0.20 to 0.15) upon monomer-monomer association. 
Yet whether or not D1 rotates upon monomer association, the data indicate that the PFO 
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molecule is still oriented in a largely “end-on” orientation (Figure 29i) since the height 
of the BODIPY probe in D1 relative to the membrane surface is about 100 Å even in the 
prepore complex. 
To determine whether monomer association and prepore formation cause the D3 
TMH1 segment to move relative to the membrane surface, we measured the extent of 
energy transfer between rPFO(F318A A215C-BODIPY) and Rh-PE, and found that 
rPFO(F318A A215C-BODIPY) had a higher FRET efficiency in the prepore oligomer 
than did rPFODS(A215C-BODIPY) in the monomeric membrane-bound state (Figure 
30B). Using eq. 6, the probe in TMH1 was determined to be 62 ± 1 Å above the 
membrane surface in the prepore complex. 
The increased FRET efficiency observed for the D3 probe upon PFO association 
to form the oligomeric prepore complex can most likely be attributed largely or solely to 
a translational movement of the D3 TMHs towards the membrane surface since the 
anisotropy values for the BODIPY dye do not change significantly (0.21 vs. 0.20) 
between the membrane-bound monomer and the prepore complex. Thus, in the prepore 
complex, the D3 TMH1 segment is located closer to the membrane surface than in the 
membrane-bound monomeric form. 
Topography of PFO in the pore complex 
To estimate the location of D1 in the pore complex, we then measured the extent 
of energy transfer between Rh-PE and rPFODS(E167C-BODIPY) under reducing 
conditions (+ DTT) that readily allowed pore formation (Ramachandran et al., 2004). 
Under these conditions, a high FRET efficiency was observed between the probes in D1 
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in the membrane-inserted pore complex and Rh-PE at the membrane surface (Figure 
30A). Using eq. 6, L was determined to be 74 ± 2 Å. 
However, the above L value actually underestimates the extent of D1 movement 
towards the membrane because the Rh-PE is no longer distributed uniformly over a 
parallel plane after the pore is formed and the internal lipid “plug” is somehow lost to 
create the pore. Instead, a donor dye in a membrane-inserted PFO ring will transfer 
energy only to Rh-PE molecules that are located within a radius of about 110 Å (~ 2R0), 
and no acceptor dyes will be present in the newly-created 300 Å-diameter aqueous pore 
(Olofsson et al., 1993). To estimate the effect that pore formation would have on the 
surface density of Rh-PE around a BODIPY probe in a pore complex, we calculated the 
fraction of the area of a circle of radius 110 Å that would overlap with a circle of radius 
150 Å if the donor dye were located at the edge of the pore (i.e., the center of the smaller 
circle was assumed to lie on the circumference of the larger circle). The extent of 
overlap under these conditions was 42%. It is therefore reasonable to assume that the 
surface density of Rh-PE molecules around each BODIPY-rPFO in an inserted pore 
complex is reduced on the order of 42%. Using this corrected σ value, L turns out to be 
65 ± 1 Å. While this number constitutes only an estimate because of the assumptions 
made in its calculation, it is clear that the probe in D1 is located far from the membrane 
surface in the PFO pore complex. It is also clear that there is a major change in D1 
location relative to the membrane surface upon pore formation, since it appears that the 
D1 probe moves (assuming that the change in FRET efficiency is due solely to 
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translational movement of D1) from about 99 Å above the membrane surface to a height 
of about 65 Å above the surface. 
As noted earlier, the location of residue 215 in the pore complex is fixed and 
known (Shatursky et al., 1999). Residue 215 in TMH1 faces the hydrophobic core of the 
membrane bilayer in the TM β-barrel and is located near the membrane surface. 
Therefore, in the pore complex, the BODIPY dye attached to this position in the reduced 
rPFODS(A215C-BODIPY) resides within the bilayer core. In this case, L << R0 and 
donor dyes transfer significant excitation energy to acceptor molecules located on both 
sides of the membrane (but not in the pore, of course). Under these circumstances, the 
use of eq. 6 is invalid. However, this limitation is unimportant in this case because our 
previous studies have determined where A215 is located in the pore complex. 
Dye orientation (κ2) effects and uncertainties in L 
The accuracy of the values determined for L (summarized in Table 5) is 
dependent upon the accuracy of the assumption that the transition dipoles of the donor 
and acceptor dyes are dynamically randomized during the excited-state lifetime of the 
donor so that κ2 = 2/3. Since the BODIPY dyes attached to the protein and the 
rhodamine dyes attached to PE (Rh-PE) and located at the membrane surface do not 
rotate with complete freedom (Table 5), there is uncertainty in the experimentally 
determined R0 and therefore, in L. Although κ2 cannot be determined experimentally in a 
non-rigid sample, the theoretical upper and lower limits of κ2, and hence of R0, can be 
calculated from the anisotropy values of the donor (rD) and the acceptor (rA) that indicate 
the freedom of rotation of the dyes in the sample (Dale et al., 1979). From the measured  
 121
 
Table 5. Distance of closest approach determined by FRET 
aL was calculated using Equation 6 as described under “Experimental Procedures”. Average values and 
standard deviations for 6 to 9 independent experiments are shown. The errors indicate experimental 
uncertainty of measurements and not uncertainties in κ2 or R0. 
bNo energy transfer was observed. 
cThis L value was determined using a reduced σ as discussed in the text. 
N.D. not determined. 
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steady-state anisotropies of vesicle-bound BODIPY-labeled rPFO and Rh-PE (Table 5), 
the maximum uncertainty in R0 due to orientation effects (κ2) was calculated to range 
from -22% to +27%. However, assuming a value of κ2 = 2/3 usually yields distances that 
differ by 10 % from those determined by crystallography when such comparisons can be 
made. This is true for both point-to-point (e.g. Stryer, 1978; Wu and Brand, 1992; also 
compare Johnson et al., 1982, with the structure of Yusupov et al., 2001) and plane-to-
plane (compare McCallum et al., 1996, with Banner et al., 1996, and Yegneswaran et al., 
1997 and 1999, with Adams et al., 2004) FRET measurements. Furthermore, because 
Rh-PE is oriented randomly in the plane of the membrane in the plane-to-plane FRET 
measurements done here, the uncertainty in R0 due to orientation effects is further 
reduced. 
Discussion 
Our FRET measurements have provided four important insights into the 
topography of membrane-bound PFO at different stages of pore formation. First, in the 
membrane-bound monomeric state, the PFO molecule is anchored to the membrane in an 
‘end-on’ orientation, with the long axis of the molecule nearly perpendicular to the plane 
of the bilayer. Second, monomer-monomer association and the formation of a prepore 
complex do not greatly alter the domain arrangement of individual PFO molecules 
relative to the membrane surface. Third, the D3 polypeptide segments that constitute the 
TMHs are far above the membrane surface even in the prepore complex, prior to 
insertion. Fourth, major changes in the overall topography and domain arrangement of 
the PFO molecule occur only during the prepore-to-pore transition of the oligomer. 
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FRET measurements between D1 of membrane-bound monomeric PFO and the 
membrane surface show conclusively that the elongated monomer is bound to the 
membrane in an ‘end-on’ orientation. Despite the fact that PFO is anchored to the bilayer 
by only a few residues at the tip of D4 that are located at one end of the molecule (Heuck 
et al., 2000; Ramachandran et al., 2002), D1 is stably positioned at the opposite end of 
the molecule more than 100 Å above the membrane surface. In addition, FRET 
measurements between D3 of membrane-bound monomeric PFO and the membrane 
surface show that TMH1 is ~ 72 Å above the membrane (Table 5). Thus, in the 
membrane-bound monomer stage of pore formation, the PFO molecule projects nearly 
perpendicularly from the plane of the membrane bilayer.  
How do these distances relate to the dimensions of crystallized PFO (Rossjohn et 
al., 1997)? In the crystal structure, the longest dimension of the PFO monomer from the 
top of D1 to the tip of D4 is 115 Å (Figure 28; Rossjohn et al., 1997). If the PFO 
monomer initially binds to the membrane in a perpendicular orientation (Figure 29i), 
then the closest distance between the top of D1 and a phospholipid headgroup, after the 
insertion of the D4 loops into the bilayer core (Ramachandran et al., 2002), would be ~ 
110 Å. If one then takes into account the lengths of the short tethers (~ 5 Å) that attach 
the BODIPY and the rhodamine dyes to the Cys residue and the phospholipid 
headgroup, respectively, then our FRET-determined distance of ≥ 100 Å between a 
BODIPY dye attached to the top of D1 to a rhodamine dye located at the membrane 
surface agrees well with an ‘end-on’ topography. 
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Also, in the ‘end-on’ orientation, the distance between residue 215 in D3 TMH1 
and the membrane surface would be ~ 50 Å based on the crystal structure (Figure 28). 
However, this distance does not agree well with the FRET-determined height of 72 Å for 
the membrane-bound monomer (Table 5). This apparent discrepancy may be explained 
by the fact that D3 is poorly packed against D2 in the PFO crystal structure, and this 
induces a marked bend in the core β-sheet that connects D1 and D3 (Rossjohn et al., 
1997), suggesting that D3 is capable of flexing away from the rest of the molecule. If 
such dynamic conformational flexibility does exist in solution, then it would not be 
surprising if D3 is, on average, positioned somewhat farther away from the membrane 
than is indicated by the solid-state structure and its crystal packing forces. 
This structural arrangement, with an elongated protein projecting stably from a 
small 'footprint' on the membrane surface, is unusual. However, it is not unprecedented. 
Proteins involved in effecting and regulating blood coagulation are elongated, bind 
reversibly to appropriate membranes with small footprints, and extend approximately 
perpendicularly from the membrane with the enzyme active sites located 70-95 Å above 
the surface (Isaacs et al., 1986; Husten et al., 1987; Armstrong et al., 1990; 
Mutucumarana et al., 1992; McCallum et al., 1996; Yegneswaran et al., 1997). 
Intriguingly, these FRET studies revealed that the active site heights and/or orientations 
were altered in all but one case when the enzymes associated with the non-enzymatic 
protein cofactors that are required to achieve physiologically-significant reaction rates to 
either promote or prevent blood clot formation (Husten et al., 1987; Armstrong et al., 
1990; McCallum et al., 1996; Yegneswaran et al., 1997). Since we later showed directly 
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by protein engineering that the cofactor requirement for enzyme activity could be 
eliminated in one case by lowering the enzyme’s active site above the membrane surface 
(Yegneswaran et al., 1999), it appears that the cofactors regulate blood coagulation, at 
least in part, by positioning the enzyme active sites at the proper height and orientation 
above the phospholipid surface to cleave their membrane-bound substrates. It therefore 
seems reasonable to suggest that the unusual 'end-on' binding of PFO to the membrane 
may have evolved to provide a topographical mechanism for ensuring that protein-
protein interactions occur in the proper sequence and thereby regulating the movement 
of PFO through the different stages of pore formation. 
In the prepore complex, the height of D1 above the membrane surface was 
determined to be about 100 Å (Table 5). Since no energy transfer was observed between 
D1 and the membrane surface in membrane-bound monomeric PFO, and since the 
BODIPY dye in the prepore complex was found to rotate more freely than that in 
membrane-bound monomeric PFO (Table 5), the increased FRET may be due to a more 
favorable alignment of the donor and acceptor transition dipoles. Whatever the case, the 
small magnitude of the FRET efficiency demonstrates that even at the prepore stage of 
pore formation, D1 is still located far above the membrane surface and PFO is bound in 
an ‘end-on’ orientation in the prepore complex (Figure 29i). 
Since PFO is presumably poised in this obligatory prepore intermediate (Heuck 
et al., 2003) to insert into the bilayer, an interesting and important structural question is 
where the D3 TMHs are located in the prepore complex. Are they positioned near or at 
the membrane surface just prior to insertion? Heuck et al. (2003) showed that residues in 
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the TMHs were not exposed to the nonpolar interior of the membrane, but they did not 
further characterize TMH positioning. Here we have used the FRET approach to 
demonstrate that the height of the D3 TMH1 above the membrane surface is ~ 62 Å. 
This substantial height above the surface reveals that the TMHs in the prepore complex, 
supposedly 'poised' to insert into the bilayer, must still move a substantial distance to 
enter the membrane. For example, the fluorophore attached to TMH1 at position 215 
must move from 62 Å above the membrane surface to a position located within the 
hydrophobic core of the bilayer. This major change in topography may explain, in part, 
why the prepore-to-pore conversion involves a substantial transition energy barrier that 
cannot be surmounted at low temperature (Heuck et al., 2003) or with some PFO 
mutants (Hotze et al., 2002; Ramachandran et al., 2004). The energy is presumably 
necessary to power the large conformational rearrangements that move the D3 TMHs to 
the membrane surface and then into the bilayer during the prepore-to-pore transition. 
 Also, the 10 Å reduction in TMH1 height above the membrane surface during 
the monomer-to-oligomer transition is not surprising because we have previously shown 
that D4 binding to the membrane triggers appreciable conformational changes in the 
spatially-distant D3 that expose an interface required for PFO oligomerization 
(Ramachandran et al., 2004). In unreduced rPFODS trapped in the membrane-bound 
monomeric state, these conformational changes are not elicited due to the presence of 
the intramolecular disulfide bond (Ramachandran et al., 2004). It therefore appears that 
one structural ramification of D4 binding to the membrane is a long-range 
conformational change in D3 that not only exposes the monomer-monomer interface 
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surface (Ramachandran et al., 2004), but also moves D3 closer to the membrane surface 
by about 10 Å. 
While TMH1 moves more than 60 Å during the prepore-to-pore transition, D1 
appears to move about 34 Å closer to the membrane surface (Table 5). This number is 
only an estimate since the loss of acceptor dyes during pore formation complicates the 
determination of σ in the latter case. However, the FRET measurements agree very well 
with the heights of the prepore and pore complexes determined using AFM. Czajkowsky 
et al. (2004) reported a distance of 73 ± 5 Å between the top of the PFO pore complex 
and the membrane surface, which agrees well with the 65 ± 1 Å distance of closest 
approach between the D1 fluorophore and the acceptor dyes at the membrane surface 
(Table 5). The observed changes in the height of the PFO complex during the prepore-
to-pore transition were also similar: ~ 40 Å for the AFM study (Czajkowsky et al., 2004) 
and ~ 34 Å (Table 5). Thus, two independent approaches agree on the magnitude of the 
structural change in the height of the PFO complex during pore formation. In addition, 
the FRET approach reveals that some PFO domain movements are even larger than 
indicated by monitoring the overall structure of the complex. 
In summary, the water-soluble PFO monomer (Figure 31i) initially anchors itself 
to a cholesterol-containing target membrane in an ‘end-on’ orientation, with its long axis 
perpendicular to the plane of the membrane bilayer (Figure 31ii). At this stage, TMH-
forming D3 segments are located ~ 72 Å above the membrane surface (Figure 31ii). 
Monomer-monomer association and subsequent prepore formation slightly lowers the 
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Figure 31. Model of the FRET-detected changes in PFO topography. A cartoon 
representation of the pathway of PFO pore formation depicting the orientation of 
membrane-bound PFO at different stages prior to membrane insertion is shown. Our 
FRET experiments reveal that water soluble PFO monomer (i) anchors itself to the 
membrane surface in an ‘end-on’ orientation with the long axis of the molecule nearly 
perpendicular to the plane of the membrane bilayer (ii). At this stage, the TMHs are 
located far (~ 70 Å) above the membrane bilayer. Prepore formation slightly reduces the 
height of the molecule above the membrane surface (iii), as well as the height of TMH1 
in D3 above the membrane surface. During the prepore-to-pore transition, the molecule 
experiences a significant reduction in height (from ~ 100 Å to 65 Å) that brings D1 
closer to the membrane surface, while TMH1 in D3 is inserted into the nonpolar core of 
the bilayer as part of the TM β-barrel. For simplicity, only one monomer in the prepore 
(iii) and pore (iv) complexes are shown. 
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heights of both D1 and D3 above the membrane surface (Figure 31iii). Concomitant with 
the prepore-to-pore transition, the molecule experiences a marked reduction in height 
above the membrane surface from ~ 100 Å in the prepore complex to ~ 65 Å in the 
membrane-inserted pore complex (Figure 31iv). Since D4 projects perpendicularly from 
the membrane even in the pore complex (Ramachandran et al., 2002), the reduction in 
height is presumably caused by a downward collapse of D2, as suggested by 
Czajkowsky et al. (2004). Thus, major topographical changes in PFO structure 
accompany pore formation as depicted in Figure 31. 
In general, the changes in protein conformation that accompany the transition of 
several pore-forming toxins from one stably-folded state in water to a differently-folded 
membrane-inserted state within the target bilayer have been noted to be relatively 
modest (Montoya et al., 2003; Collier and Young, 2003). For example, in the case of the 
S. aureus α-HL, the TM β-hairpin that each monomer contributes to the 14-stranded β-
barrel originates simply as an extension of its core β-sheet with minimal changes to 
either the secondary structure or the topography of its oligomeric prepore complex on 
the membrane surface (Song et al., 1996; Olson et al., 1999; Montoya et al., 2003). 
However, as described here, the changes in both PFO secondary structure and 
topography are substantial during pore formation, thereby demonstrating that the 
mechanisms of pore formation differ for CDCs and other toxins. 
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CHAPTER VI 
SUMMARY 
Using multiple independent fluorescence techniques as primary tools, the 
research presented in this dissertation has elucidated the mechanisms by which, the pore-
forming toxin PFO from C. perfringens, binds to, and oligomerizes on the surface of, 
cholesterol-containing membranes. In addition, the topography of the molecule relative 
to the membrane surface at each stage of pore formation has been determined.  
In summary, D4, the domain that first interacts with the target membrane anchors 
PFO to the membrane surface via the short hydrophobic loops at the tip of its β-
sandwich. Only these loops are exposed to the nonpolar core of the bilayer, while the 
remainder of D4 is surrounded by water. D4 projects vertically from the membrane 
surface and its orientation relative to the membrane surface remains unaltered even after 
pore formation. Moreover, D4 makes little or no contact with neighboring monomers in 
the oligomer. Thus, initial binding of PFO to the target membrane is accomplished. The 
impact of these findings and the role of D4 in pore formation have been discussed in 
detail in Chapter III. 
Membrane binding elicits multiple structural rearrangements in PFO that initiate 
and regulate its oligomerization. D4-membrane interactions trigger the movement of a 
loop in the spatially-distant D3 that exposes the edge of a previously-hidden β-strand. 
This β-strand interacts with an already-exposed β-strand of an adjacent monomer to 
form the monomer-monomer interface. The exposure of this β-strand is necessary for 
productive collisional encounters between membrane-bound PFO monomers on the 
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membrane surface and the formation of a large, circular prepore complex. Remarkably, 
the β-strands that form the interface each contain a single aromatic residue, and these 
aromatics appear to stack to align the TMHs of adjacent monomers in the proper register 
for insertion. Thus, membrane-dependent conformational changes initiate and regulate 
oligomerization and pore formation. The significance of these fndings is discussed in 
Chapter IV. 
FRET measurements revealed the topography of PFO relative to the membrane 
surface at each stage of pore formation. The elongated PFO monomer is initially 
anchored to the membrane surface in an ‘end-on’ orientation with its long axis nearly 
perpendicular to the plane of the membrane bilayer. This orientation remains relatively 
unaltered even upon monomer-monomer association and prepore complex formation. 
However, the oligomeric complex undergoes a significant collapse in height concomitant 
with membrane insertion and pore formation. Furthermore, the polypeptide segments 
that constitute the TMHs are located far above the membrane surface even at the prepore 
complex stage of pore formation, thereby indicating that the major topographical 
changes in PFO occur during the prepore-to-pore transition of the oligomer. The 
importance of these findings is discussed in Chapter V. 
The results from this study have thus helped bridge many of the gaps that exist in 
our current knowledge of CDC pore formation. However, many intriguing questions still 
remain. For example, the trigger for the helix-to-sheet conversion in D3 is unknown. It is 
tempting to believe that exposure of the TMH-forming α-helices to the low dielectric 
constant environment of the lipid-water interface (White and Wimley, 1999) triggers this 
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event. However, till date, no experiments have been targeted at addressing this issue. 
How are the lipids in the middle of the circular, oligomeric prepore complex displaced to 
create the large aqueous pore? This poses a conceptual problem because creation of a 
300 Å pore requires the displacement of more than a 1000 lipid molecules from the 
middle of the oligomeric complex. How this is accomplished concomitant with TMH 
insertion remains obscure and demands further experimentation. Finally, and most 
important, the exact role of cholesterol in the pore formation process is still unclear. Do 
CDCs have a specific binding site for cholesterol? If so, what is the stoichiometry of the 
PFO:cholesterol complex? Answers to these questions have been hard to come by and 
demand ingenuity and creativity in experimental design. 
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Figure 32. Pore formation by NBD-labeled D4 mutants. Time-dependent emission 
intensity profiles for liposome-encapsulated [Tb(DPA)3]3- (50 µM total lipid) when 
incubated with 50 nM of a NBD-labeled rPFO mutant (see key) at 37oC in buffer D 
containing 5 mM EDTA. The release of liposome-encapsulated [Tb(DPA)3]3- was 
monitored as described in Experimental Procedures. For comparison, profile for rPFO is 
also shown. 
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Figure 33. Pore-formation assay for rPFO(V322C-NBD) and rPFO(G324V G325V). 
Time-dependent emission intensity profiles for liposome-encapsulated [Tb(DPA)3]3- (50 
µM total lipid) when incubated with 50 nM of the indicated rPFO mutant at 37oC in 
buffer D containing 5 mM EDTA. The release of liposome-encapsulated [Tb(DPA)3]3- 
was monitored as described in Experimental Procedures. For comparison, profile for 
rPFO is also shown. 
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Figure 34. Trp emission intensity time traces for rPFO mutants. Time-dependent Trp 
emission intensity was measured after addition of cholesterol-containing liposomes (50 
µM) to 50 nM of (A) rPFO(G324V G325V) or (B) rPFO(T179Y Y181A F318A A320F) 
(iv in Figure 24) as described in Experimental Procedures. For comparison, profile for 
rPFO is shown. 
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Figure 35. Characterization of pyrene-labeled rPFO mutants. (A) Time-dependent 
emission intensity profiles for liposome-encapsulated [Tb(DPA)3]3- (50 µM total lipid) 
when incubated with an equimolar mixture of rPFO(T179C-Pyr) and rPFO(V322C-Pyr) 
(50 nM total),  50 nM rPFO(T179C-Pyr), and 50 nM rPFO(V322C-Pyr) at 37oC in 
buffer D containing 5 mM EDTA. The release of liposome-encapsulated [Tb(DPA)3]3- 
was monitored as described in Experimental Procedures. (B) SDS-AGE analysis of an 
equimolar mixture of rPFO(T179C-Pyr) and rPFO (4.0 µM total) in the presence or 
absence of liposomes (1 mM total lipid) and in the presence or absence of the cross-
linker glutaraldehyde as indicated. The bands were visualized by pyrene emission by 
exciting the gel on an UV transilluminator. M represents the monomer and O, the 
oligomer. 
A 
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Figure 36. Pyrene-excimer formation is dependent on the proximity of pyrenes. Pyrene 
emission spectrum for an equimolar mixture of rPFO(Y181C-Pyr) and rPFO(V322C-
Pyr) (100 nM total) in the presence of cholesterol-containing liposomes (100 µM lipid) 
was measured as described under Experimental procedures. Lack of excimer formation 
indicates that the pyrenes attached to these residues are not in close proximity to stack in 
the mixed PFO oligomer. 
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